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Summary 
Due to the use of a great number of existing chemicals and many new being produced, 
there is a strong need for efficient and cost-effective methods, in order to classify and regulate 
the use and release of these potential environmental pollutants. Effects on the environment 
and on human health have been described for many important toxicants; there is however a 
great lack of studies addressing the effects of co-exposures from such harmful agents. 
Toxicogenomics is a scientific field under continuous improvement and represents a hallmark 
of future toxicological research. Toxicogenomics has a great potential in relation to 
classification and risk assessments of environmental contaminants.  
The aim of this study was to elucidate the complex nature of co-exposures to toxicants by 
combining traditional toxicological tests with modern microarray technology. We investigated 
the effects of two well documented toxic agents; the heavy metal cadmium, and UVC 
irradiation (< 280 nm). Cadmium elicits many genotoxic effects, including inhibition of 
Nucleotide Excision Repair (NER). UVC induces DNA-lesions, mainly cis-syn cyclobutane 
pyrimidine dimers (CPDs) which are repaired by NER. NER plays a key role in the removal 
of DNA-damage caused by various toxicants. Different modes of action of cadmium and 
UVC make them good models for our investigations. Human testicular cancer cells (833K) 
were exposed to cadmium (CdCl2•2,5H2O) and UVC radiation; relevant doses were 
determined by measuring cell viability, and cell-cycle responses to treatments were estimated 
by flow cytometric analysis. DNA-repair efficiency of cells pre-incubated with 5 µM Cd2+ 
and exposed to UVC (1 J/m2), was assessed by measuring DNA single strand breaks (SSBs) 
using the alkaline elution assay. Global gene expression profiles were estimated from 
microarrays, whereas induction of specific proteins was measured by Western analysis. We 
found that cadmium treatment led to significant attenuation of DNA-repair of UVC induced 
lesions. Microarray analysis demonstrated differences in gene-expression profiles in response 
to both cadmium and UVC treatments, whereas Western analysis displayed differences in 
induction of specific proteins involved in DNA repair, cell cycle and apoptosis. In accordance 
with other studies we have found cadmium to elicit important co-genotoxic effects, especially 
affecting the removal of DNA damage performed by NER.  
We conclude that microarrays and traditional experimental toxicology, as used in the 
present investigations, represent adequate means to study the combined effects of toxicants.  
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1. Abbreviations 
8-oxo-dG 8-oxo-2'-Deoxyguanosine 
β-ME β-Mercaptoethanol 
6-4PPs Pyrimidine (6-4) Pyrimidone Photoproducts 
8-oxo-dGTPase 8-oxo-2'-deoxyguanosine5'-triphosphate pyrophosphohydrolase 
AP site (Abasic) apurinic/apyrimidinic site 
Ape1 Mammalian AP Endonuclease 1 
AraC Cytosine Arabinoside 
AraCTP Cytosine Arabinoside Triphosphate 
AS Australian Calf Serum 
BER Base Excision Repair 
BPB Bromo Phenol Blue 
BSA Bovine Serum Albumin 
PTWI Provisional Tolerable Weekly Intake 
CAT Catalase 
cDNA Complementary DNA 
CPDs cis-syn Cyclobutane Pyrimidine Dimers 
CSA Cockayne Syndrome Factor A 
CSB Cockayne Syndrome Factor B 
CTD  Comparative Toxicology Database 
Cy3 Cyanine 3 
Cy5 Cyanine 5 
DDB2 UV-DNA Damage Binding Protein, subunit 2 
DNA MeTase DNA (5-cytosine) Methyltransferase  
EBI European Bioinformatics Institute 
eGOn Explore Gene Ontology 
ERCC1 Excision Repair Cross Complementing Group 1 
ERK1 Extracellular Signal-Regulated Kinase 1 
ERK2 Extracellular Signal-Regulated Kinase 2 
FEN1 Flap-structure Specific Endonuclease 1 
Fpg Formamido-Pyrimidine-DNA Glycosylase  
GAPDH Glyceraldehyde-3-Phosphate Dehydrogenase  
GEO Gene Expression Omnibus 
GEPAS Gene Expression Pattern Analysis 
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GGR Global Genome Repair 
GO Gene Ontology 
GPx Peroxidase 
GSH  Glutathione 
HAP1 Human AP-Endonuclease 1 
HRP Horseradish Peroxidase 
HU Hydroxyurea 
IARC International Agency for Research on Cancer 
JNK c-JUN N-terminal Kinase 
LPR Long-Patch Repair 
MAPK Mitogen Activated Protein Kinase 
MBD Minor DNA Binding Domain 
MGMT O6-Methylguanine-DNA Methyltransferase 
MIAME Minimum Information About a Microarray Experiment 
MIAN Department of Analytical Chemistry 
MIKT Department of Chemical Toxicology 
MMR Mismatch Repair 
MT Metallothionein 
NER Nucleotide Excision Repair 
NMC Norwegian Microarray Consortium  
NAAC Normalised Area Above (the elution) Curve 
P/S Penicillin & Streptomycin 
PARP Poly (ADP-ribosyl)ation 
PARPs Poly(ADP-ribose) Polymerases 
PCNA Proliferating Cell Nuclear Antigen 
PI Propidium Iodide 
PKC Protein Kinase C 
Pol β Polymerase β 
RFC Replication Factor C 
RIN RNA Integrity Number 
ROS Reactive Oxygen Species 
RPA Replication Protein A  
RT (enzyme) Reverse Transcriptase 
RT-PCR Reverse Transcription Polymerase Chain Reaction 
SDS Sodium Dodecyl Sulphate 
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SDS-PAGE SDS-Polyacrylamide Gel Electrophoresis 
SOD Superoxide Dismutase 
SPR Short-Patch Repair 
SSBs DNA Single Strand Breaks 
T4-pdg (bacteriophage)T4-Pyrimidine Dimer Glycosylase 
TCR Transcription-Coupled Repair 
TFIIH Transcription Factor IIH 
TGCT Testicular Germ Cell Tumour 
TTD Trichothiodystrophy 
UV-DDB UV-DNA Damage Binding Protein 
XP, A-G Xeroderma Pigmentosum -Complementation group A-G 
XRCC1 X-ray Cross Complementing Protein 1 
 
 
 
*In this study genes are denoted by italic names.  
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2. Introduction 
2.1. Environmental exposure 
Already from the moment of conception we are continually exposed to a plethora of 
hazardous chemical and physical agents that can be deleterious to our health. These include 
food contaminants, ionising radiation, UV-sunlight, industrial and municipal wastes, toxic ion 
metals, emissions from fossil fuel combustions and refuse incinerations, pesticides and 
thousands of other manmade chemicals. There is an ever ongoing elaborate research 
worldwide to map and regulate the use and release of potentially harmful agents, yet their 
effects on the environment and on human health have only been described for relatively few 
pollutants. Furthermore, there is a great shortage of information addressing the combined 
effects of toxicants. Consequently, due to the very large number of chemicals, there is a great 
need for reliable and time-efficient methods to assess environmental and human health risks. 
Toxicogenomics is a rapidly growing scientific discipline which is very promising and 
specifically designed to address these problems.  
2.2. Aim of this study  
We wished to investigate the effects of co-exposures to environmental pollutants using a 
toxicogenomic approach, by merging classic in vitro test methods with modern microarray 
technology. In order to understand the complexity behind combined effects of toxicants, it is 
necessary to first establish a platform from where to commence. We therefore chose to 
investigate two appropriate model agents, for which the biological effects are well 
documented. Our choices fell on the ubiquitous environmental pollutant cadmium, and UVC 
(<280nm) irradiation. Cadmium is a “modern time” contaminant of considerable importance 
to human health and causing environmental concern. Some studies have shown that cadmium 
interferes with DNA repair mechanisms, including Nucleotide Excision Repair (NER), and 
was therefore chosen as a suitable candidate for our study (Fatur et al., 2003). UVC exposure 
is not relevant from a public health point of view, since essentially all of it is absorbed by 
atmospheric ozone. However, we chose UVC because of its ability to induce well-defined 
DNA lesions; the most frequent being cis-syn cyclobutane pyrimidine dimers (CPDs) and the 
pyrimidine (6-4) pyrimidone photoproducts (6-4PPs), reviewed by (Pfeifer et al., 2005). In 
human cells the UVC-induced lesions are mainly handled by NER, which is also extensively 
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involved in the repair of a great number of different DNA insults caused by various 
environmental pollutants.  
2.3. The principles of toxicogenomics 
Toxicogenomics seeks to understand how the genome is involved in responses to 
environmental stressors and toxicants. Toxicogenomics combines studies of genetics, mRNA 
expression, cell and tissue-wide protein expression, and metabonomics to understand the role 
of gene-environment interactions in disease. Fundamental to toxicogenomics research is the 
use of technologies related to transcriptional profiling, e.g. microarrays. Due to the vast 
amount of biological information being generated in this field, the development and 
application of bioinformatic tools and databases are crucial in order to facilitate the mining, 
analysis, visualisation and sharing of data. This rapidly growing research area is apt to have a 
large impact on toxicological studies in terms of analysis and classification of chemicals, risk 
assessments, and will undoubtedly help unravel questions as to how components of biological 
systems work together and how different organisms respond to specific stresses, drugs, or 
toxicants. 
2.4. The basics of microarray analysis  
Microarray technology provides a powerful tool that is essential to the field of 
toxicogenomics. DNA or oligonucleotide microarrays are used to simultaneously assess the 
transcriptional states of tens of thousands of genes in response to treatment. For instance when 
an organism or cell is exposed to a foreign toxic chemical or other detrimental insults, gene 
expression patterns get altered, e.g. by elevated transcription of protective enzymes or cell-
cycle regulators. The change in mRNA levels of affected genes is probably the first detectable 
response, and those changes can be discovered by microarrays. 
Briefly described, thousands of short DNA segments, called probes, are fixed on a 
surface (glass or nylon) and constitute a microarray, each of these segments of DNA 
representing a single gene. Isolated mRNA from treated cells or tissues is used to make 
complementary DNA (cDNA) using reverse transcription (in cases with very little RNA, the 
cDNA may be amplified by a polymerase chain reaction (PCR)). The cDNA, called the target, 
is tagged with a fluorochrome and hybridised onto the probes on the microarray. Likewise a 
cDNA target is prepared from a control sample (usually untreated cells of the same type). If 
only one fluorochrome is used, the control and experimental samples are hybridised onto 
separate microarrays. If two fluorochromes are used, the samples are hybridised onto a so-
 12 
called two-colour microarray. Only the latter approach is used and will be described in this 
thesis. Following hybridisation the fluorochromes are excited by laser simultaneously as the 
array is scanned. Intensity ratios of emitted light from the fluorochromes are calculated by 
computer programmes and represent the amount of control and experimental target that has 
hybridised to each probe on the microarray. Through the use of specially designed software 
for microarray analysis, each target-to-probe hybridisation (spot) is examined, discarding 
spots of poor quality. Statistical tools are used to normalise the remaining data in order to 
exclude technical variance. Intensities from the spots are transformed into numeric values, 
which are used to classify genes of the treated sample as either up or down-regulated, 
compared to the control. Further processing usually includes sorting the genes into clusters, 
which is a reasonable approach; for one, genes displaying similar expression patterns tend to 
be co-regulated and second, co-regulated genes may be involved in the same metabolic 
pathways. Two methods of gene clustering extensively used in toxicogenomics are;  
●Hierarchical clustering: Total gene expression profiles from different or parallel 
experiments are compared to each other and related in terms of similarity. The design of 
hierarchical clustering is much like a family tree; clusters divided by short branches share 
many of the same properties in response to treatment, while those further apart have less in 
common.  
●K means clustering: Genes are sorted into clusters on account of similarity, but the 
number of clusters is already determined in advance. Each expressed gene is assigned to one 
cluster, and then reassigned to the next. The method “forces” each gene into the closest 
related cluster, minimising the differences within each cluster, while at the same time 
maximising differences between the cluster groups. After clustering, the data can be more 
thoroughly investigated and used to create individual or overall gene-expression profiles for 
the treatment in question.  
The transcriptional profiles elicited by microarrays show great promise in identification 
and characterisation of hazardous chemicals. The profiles obtained for known toxicants can be 
used to prioritise further investigation of those compounds that show similar expression 
patterns. The concept is based on the assumption that chemicals that exert similar effects also 
invoke similar transcriptional responses.  
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2.4.1. Toxicogenomic databases 
Two of the greatest challenges facing toxicogenomics are; how to share the enormous 
amount of data created by microarray experiments, and how different data sets can be related 
to one and other across laboratories (Hayes et al., 2005). Several web accessible databases 
have been created in order to facilitate the processing and distribution of microarray results. 
There are however many different protocols and platforms available to the scientific 
community, hence a standardised technical report on how the data is obtained is crucial in 
order to interpret and compare related conclusions from other studies. To overcome this 
problem, the Microarray Gene Expression Data Society proposed the “Minimum Information 
About a Microarray Experiment” (MIAME) -guidelines, for reporting and publication of 
microarray experiments. Most journals today require that papers containing microarray 
experiments follow the MIAME guidelines. Standardisation has helped reducing variation 
across laboratories, but the work is difficult. The matter is further complicated by different 
nomenclatures used across laboratories to annotate targets, a result of differing informatics 
tools. But the situation is improving, and several open-access genomic databases with 
relevance to toxicology are now available providing toxicologists with resources for improved 
interpretation of profiling experiments. The largest databases in use today are Gene 
Expression Omnibus (GEO), at the National Centre for Biotechnology Information 
(http://cebs.niehs.nih.gov/microarray/index.jsp), and Array Express (http://www.ebi.ac.uk/ 
arrayexpress/) both are adherent to MIAME guidelines. GEO houses over 18000 microarray 
experiments from a large number of biological fields, however only a small fraction of the 
database contains data from toxicological experiments. Array Express is based at the 
European Bioinformatics Institute (EBI) and contains data from over 5000 microarray 
hybridisations. Array Express has developed a subsystem called Tox-MIAME express, which 
works by incorporating descriptive data about toxicological experiments, e.g. dose used, route 
of administration, duration of treatment etc.  There are also numerous databases under 
development with direct application to toxicogenomics such as the dbZach database and the 
Comparative Toxicology Database (CTD). dbZach for instance will house microarray data 
and provide analysis tools with particular emphasis on endocrine disruption and testicular 
toxicity, whereas CTD will focus on associations between toxic agents and biological 
systems. Eventually all such databases will be linked providing toxicologists with a rich 
online resource, facilitating the understanding of chemical actions, classification of hazardous 
compounds, and ultimately also (of course) risk assessment.  
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2.5. Cadmium  
Cadmium is a relatively rare element (0.2 mg/kg in the earth’s crust); it is not found in 
pure state in nature and is almost always recovered as a by-product from the processing of 
sulphide ores of zinc, lead and copper (WHO, 2000). Little cadmium has been produced prior 
to the early 1920s and over 65 % of the cumulative world production has taken place in the 
last few decades.  
2.5.1. Use 
Cadmium is used in a wide variety of consumer and industrial materials, the main 
applications falling into five categories: 1) protective plating on steel, 2) stabilisers for 
polyvinyl chloride (PVC), 3) pigments in plastics and glasses, 4) electrode material in nickel-
cadmium batteries, and 5) as a compound in various alloys (IPCS, 1992; WHO, 2000; IARC, 
1993). 
2.5.2. Environmental exposure 
Atmospheric emissions of cadmium from anthropogenic sources exceed those of natural 
origin (volcanoes and forest fires) by an order of magnitude (IARC, 1993). Sources of 
manmade emissions to the atmosphere include mining for zinc and cadmium, copper and lead, 
fossil fuel combustion, iron and steel production, sewage sludge and waste incineration, 
phosphate fertiliser and cement manufacture. At the global level the smelting of nonferrous 
metal ores has been estimated to be the largest human source of cadmium released into the 
aquatic environment through mine drainage water, wastewater and rainwater run-off from 
mine areas. Other human sources are spent solutions from plating operations and phosphate 
fertilisers, solid-waste deposits and wastewater of both municipal and industrial origin. With 
increasing acidification of soil due to acid rain and the use of fertilisers, increased uptake of 
cadmium from soil may occur. Plants may be contaminated by cadmium through two routes: 
soil-plant transfer, due to absorption of mobile forms of cadmium through the roots, or by air-
plant transfer, due to deposition of soluble forms of cadmium particles on the epigleal parts of 
the plant. Figure 2.1 shows the percentage contribution of cadmium discharge to the 
environment from different sources in Norway 2002 (www.sft.no/2005). 
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Figure 2.1 The Norwegian national emission of cadmium into the environment has been strongly reduced 
during 20 years. In 1985 a total of ~ 43 tonnes of cadmium was released into the environment compared to 2 
tonnes in 2002. Atmospheric deposition of cadmium however is far greater then the national input. Data from 
Norwegian Pollution Control Authority (SFT) 2005  
2.5.3. Human exposure 
2.5.3.1. Exposure through air 
Most of the cadmium found in air is associated with particular matter in the respirable 
range (diameter 0.1-1 µm) (WHO, 2000). Cadmium is emitted to the atmosphere 
predominantly as elemental cadmium and cadmium oxide, but also as cadmium sulphide from 
coal combustion and nonferrous metal production or as cadmium chloride from waste 
incineration. The relative deposition of inhaled cadmium in the lungs varies between 10-50 % 
depending on the size of the airborne particles, and the absorption of cadmium depends on the 
chemical nature of the particles deposited. Absorption of cadmium oxide is about 50 % but 
considerably less for insoluble salts like cadmium sulphide.  
2.5.3.2. Occupational exposure 
The major occupational exposures occur in smelting and refining of zinc, lead and copper 
ores, electroplating, manufacture of cadmium alloys and of pigments and plastic stabilisers, 
production of nickel-cadmium batteries and welding. Other exposed occupations include paint 
production and use, pesticide production and use, phosphorus production, textile printing, 
glasswork, laser cutting and more (IPCS, 1992; IARC, 1993). 
 16 
2.5.3.3. Smoking 
Tobacco plants naturally accumulate relatively high concentrations of cadmium in the 
leaves (Waalkes, 2003; IARC, 1993). The cadmium content of cigarette tobacco is generally 
1-2 µg per cigarette, so a person who smokes 20 cigarettes per day has an estimated daily 
intake of 2-4 µg and accumulates 0.5 mg cadmium in one year. Smoking is thought to double 
the life time body burden of cadmium in non-occupationally exposed persons. 
2.5.3.4. Food 
For non-smokers and non-occupationally exposed people, food constitutes the principal 
environmental source of cadmium (WHO, 2000). The lowest concentrations are found in milk 
(around 1 µg/kg). The concentration of cadmium is in the range 1-50 µg/kg in meat, fish and 
fruit and 10-300 µg/kg in staple foods such as wheat, rice and potatoes. Highest cadmium 
levels (100-1000 µg/kg) are found in the internal organs (kidney and liver) of mammals and in 
certain species of mussels, scallops and oysters. Some crops, such as rice, can accumulate 
considerable amounts of cadmium (more than 1000 µg/kg). The average daily intake of 
cadmium via food in European countries and North America is 15-25 µg but there may be 
large variations depending on age and dietary habits. The gastrointestinal absorption of 
cadmium in humans amounts to about 5 % but may be increased by nutritional factors (up to 
15 % in iron deficiency). The average amount of cadmium absorbed via food can thus be 
estimated at 1 µg/day. The World Health Organisation (WHO) has established a provisional 
tolerable weekly intake (PTWI) for cadmium of 7µg/kg body weight (FAO/WHO, 2003). 
This illustrates a low margin of safety and that even a minor increase in cadmium intake may 
lead to significant health problems.  
2.5.4. Toxicokinetics 
The main metabolic feature of cadmium is an exceptionally long biological half-life 
resulting in a virtually irreversible accumulation of the metal in the body throughout life 
(WHO, 2000). The two main storage sites for cadmium in the body are the liver and the 
kidney. For low-level exposures such as those occurring in the general environment, about 30-
50 % of the cadmium body burden is stored in the kidneys alone, with concentrations in the 
renal cortex about 1.25 times higher than in the kidney as a whole. In non-occupationally 
exposed subjects the concentration of cadmium in the liver increases continuously with age. 
The concentration of cadmium also increases in the renal cortex but only until the age of 50-
60 years, after which it levels off or even decreases. In Europe, mean concentrations of 
cadmium in the renal cortex in the age group 40-60 years are in the range 15-50 mg/kg. 
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Concentrations are usually 50-100 % higher in current or ex-smokers than in non-smokers. In 
industrial workers the concentrations can be considerably higher. In the tissues, cadmium is 
mainly bound to metallothioneine (MT), a low-molecular-weight protein (MW 6.6 kD) rich in 
cysteine residues. Metallothioneine is involved in the transport of cadmium from the liver to 
the kidney, the cadmium-metallothioneine complex released from the liver being rapidly 
filtered through the glomeruli and then reabsorbed by the tubules. Cadmium is eliminated 
mainly via urine, however the amount excreted is very small; it represents only about 0.005-
0.01 % of the total body burden. Consequently the biological half-life for cadmium is 20-40 
years.  
2.5.5. Toxicological effects  
Acute toxic effects of short term exposures to high levels of inhaled cadmium fume 
include chemical pneumonitis with pulmonary oedema, which may be lethal (IPCS, 
1992;WHO, 2000). High levels of ingested soluble cadmium salts cause nausea, stomach-
ache and acute gastroenteritis. Effects of long-term occupational exposure to cadmium 
include respiratory illnesses such as chronic obstructive lung disease, bronchitis and 
emphysema. The kidney is the critical organ in both long-term occupational and 
environmental exposure. The accumulation of cadmium in the renal cortex leads to renal 
tubular dysfunction with impaired re-absorption of e.g. amino acids, glucose and proteins. 
Exposure to cadmium has been linked to a number of adverse health effects in a variety of 
tissues and organs (reviewed in (Waisberg et al., 2003); (Satarug et al., 2003); (Waalkes, 
2003). These include irreversible renal tubular injuries, eosinophilia, hypertension, 
osteoporosis, anaemia and cancer in several organs such as the lung, kidney, urinary bladder, 
pancreas, breast and prostate. 
2.6. Carcinogenic effects of cadmium 
In 1993, the International Agency for Research on Cancer (IARC) classified cadmium 
and cadmium compounds as group 1 human carcinogens. (IARC, 1993). The classification 
was based primarily on cadmium characteristics as a lung carcinogen. The carcinogenesis of 
cadmium is not yet fully understood but has been linked to several properties; these include 
inhibition of DNA repair mechanisms, elevated levels of reactive oxygen species, induction of 
oncogens, inhibition of tumour-suppressor genes, disruption of cell adhesion, and selection 
for apoptosis resistant cells (Waisberg et al., 2003). Molecular effects of cadmium are 
summarised in Figure 2.2. In the present study we have primarily focused on aspects 
concerning DNA repair.  
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Figure 2.2 The figure displays the numerous ways in which cadmium is thought to elicit its genotoxicity 
(Waisberg et al., 2003).  
2.6.1. DNA repair 
The human genome is built up by 3 billion nucleic acid base-pairs encoding for some 
20 000 – 25 000 genes (Human Genome Project). It consists of large double helix molecules 
which in non-dividing cells are supercoiled and tightly packed into chromosomes residing 
within the nucleus. The DNA is accessed by a wide range of different proteins which act in 
concert to relax the chromosome structure, unwind DNA strands, and initiate transcription of 
genes required for cell maintenance, tissue functions or cell proliferation. Due to its chemical 
properties and size the DNA is susceptible to a great many mechanical and chemical stresses 
both by endogenous processes as well as by attacks from a large number of exogenous DNA 
damaging agents. Endogenous (by)products include reactive oxygen species (ROS) like 
superoxide anions, hydroxyl radicals and hydrogen peroxide, derived from normal oxidative 
respiration and lipid peroxidation. The consequences of allowing DNA damage go unchecked 
is all evident in cancer development, which ultimately is caused by mutations in critical genes 
like oncogenes or tumour-suppressor genes resulting in faulty DNA replication and 
uncontrolled cell proliferation. To overcome the otherwise deleterious effects of DNA 
damage, evolution has provided us with several highly efficient DNA repair mechanisms. 
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There are four main mechanisms: nucleotide excision repair (NER), base excision repair 
(BER), mismatch repair (MMR) and recombination repair which constitutes homologous 
repair (HR) and end joining (EJ) (Hoeijmakers, 2001b; Hoeijmakers, 2001a; Fleck et al., 
2004). In this study we have focused predominately on NER, but also on BER since cadmium 
is involved in ROS generation. 
2.6.2. Nucleotide excision repair (NER) 
Of all the repair mechanisms NER is the most versatile when it comes to recognition of 
DNA lesions, and it removes a wide variety of DNA damage including photoproducts induced 
by UV and (other) bulky adducts caused by exogenous agents e.g. polycyclic aromatic 
hydrocarbons (PAHs) (Fleck et al., 2004; Hoeijmakers, 2001b; Olsen et al., 2005). At least 
three human syndromes are associated with aberrant NER: 1) Xeroderma pigmentosum (XP) 
caused by mutations in one of seven genes (XP-complementation group A-G), 2) Cockayne 
syndrome (CS) caused by mutations in the CSA or CSB genes, and 3) Trichothiodystrophy 
(TTD). All three syndromes are characterised by extreme sensitivity to sunlight. NER is 
divided into two sub-pathways (Figure 2.3): ●global genome repair (GGR), which removes 
damage in the genome overall, and ●transcription-coupled repair (TCR), which especially 
repairs the transcribed strand of active genes. The main difference between GGR and TCR is 
the recruitment of different factors during the initial recognition of DNA damage. A UV-
DNA damage binding protein (UV-DDB consisting of DDB1 and DDB2), and XPC are 
involved in the recognition step of GGR, while TCR is thought to be recruited by RNA 
polymerase II stalled at a lesion. The stalled polymerase needs to be displaced to make the 
lesion accessible for repair, and this requires at least two TCR-specific factors, CSA and CSB. 
The proteins acting further downstream in GGR and TCR are likely to be identical. First a 
complex consisting of nine subunits called transcription factor IIH (TFIIH) is recruited to the 
damage site, where after the initial recognition factors are probably released from the 
damaged DNA. Two helicases which are subunits of TFIIH; XPB and XPD, unwind ~30 
base-pairs around the lesion through helicase activity. Next the factors XPG, XPA and RPA 
(replication protein A) bind to the damaged site. XPA-RPA verifies whether the NER 
complex is correctly assembled and ensures proper incision of the damaged DNA strand. 
XPG and XPF-ERCC1, which are endonucleases, perform a dual incision; they cut 3' and 5' to 
the damage, respectively. The damage is released in a 24-32 nucleotide long oligonucleotide. 
Subsequently the resulting gap is filled by DNA polymerase and ligated. 25 proteins or more 
are thought participate in NER.  
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Figure 2.3 The Nucleotide Excision Repair (NER) pathway. See text for description of the pathway. 
Abbreviations: XPA-G, xeroderma pigmentosum complementing group A-G; RNA Pol II, RNA polymerase II; 
CSA and CSB, Cockayne syndrome factors A and B; TFIIH, general transcription factor IIH; ERCC1, excision 
repair cross complementing group 1; RPA, replication protein A; PCNA, proliferating cell nuclear antigen; 
RFC, replication factor C; Polδ/ε, DNA polymerase delta/epsilon; Lig1, ligase 1  (Olsen et al., 2005). 
2.6.3. Base excision repair (BER) 
BER mainly repairs non-bulky DNA lesions produced by alkylation, oxidation or 
deamination of bases, caused by either endogenous processes or exogenous DNA damaging 
agents (Hoeijmakers, 2001b; Fleck et al., 2004; Olsen et al., 2005). BER is divided into two 
pathways (Figure 2.4); short-patch repair (SPR) which is the main pathway in mammals, and 
long-patch repair (LPR). Cells have several DNA glycosylases, each with high specificity to 
DNA substrates, which recognise and remove damaged or modified bases. The glycosylases 
remove the damaged base by cleaving the N-glycosylic bond to the DNA sugar-phosphate 
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backbone, leaving an (abasic) apurinic/apyrimidinic site (AP site). The AP site can also occur 
spontaneously by hydrolysis and represent damage itself.  There are two main types of DNA 
glycosylases; mono and bi-functional. Bifunctional glycosylases cleave the sugar-phosphate 
backbone 3´ to the AP site through an associated AP-lyase activity, which leaves a single 
strand break (SSB). The resulting abasic sugar residue is removed by either an AP-
endonuclease or by DNA polymerase β (Pol β). The one-nucleotide gap is then filled by 
polymerase β and ligated. The processing of AP sites created by monofunctional glycosylases 
on the other hand, first require a 5´ incision by an AP-endonuclease, which is usually 
preformed by human AP-endonuclease 1 (HAP1). After this incision polymerase β inserts the 
missing nucleotide and removes the 5´ moiety through its deoxyribophosphodiesterase 
(dRPase) activity. The remaining nick is sealed by a complex consisting of DNA ligase III, 
and X-ray cross complementing protein 1 (XRCC1). The second pathway, LPR is probably 
required for AP sites where the 5´ moiety cannot be removed by dRPase activity. LPR 
involves the DNA polymerases β and δ or ε, which together with proliferating cell nuclear 
antigen (PCNA) and replication factor C (RFC) create a flap-structure of 2-8 nucleotides that 
include the AP site. The flap structure is then removed by flap-structure specific endonuclease 
1 (FEN1). DNA ligase 1 then seals the gap. 
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Figure 2.4 The Base Excision Repair (BER) pathway. See text for description of the pathway. Abbreviations: 
HAP1, human AP endonuclease 1; Polβ; DNA polymerase β; XRCC1, X-ray cross complementing protein 1; Lig 
III, DNA ligase III; PCNA, proliferating cell nuclear antigen; RFC, replication factor C; Polδ/ε, DNA 
polymerase delta/epsilon; FEN1, Flap endonuclease; Lig1, DNA ligase 1 (Olsen et al., 2005). 
2.6.4. Cadmium Inhibition of DNA repair 
Cadmium is not able to catalyse the Fenton reaction and create oxygen radicals in its own 
right, but several studies have shown cadmium to cause oxidative DNA damage in a dose- 
dependent manner (Atesi et al., 2004; Stohs et al., 1995). Cadmium tends to reduce cellular 
content of glutathione (GSH), an important detoxifier of cadmium, and in general depresses 
levels of antioxidants and protective enzymes like superoxide dismutase (SOD), peroxidase 
(GPx) and catalase (CAT), resulting in an indirect increase of oxidative stress in cells (Uchida 
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et al., 2004; Casalino et al., 2002). A study by Bialkowski and co-workers (Bialkowski et al., 
1999) showed that cadmium treatment resulted in a loss of up to 50 % in activity of the 
enzyme 8-oxo-2'-deoxyguanosine 5'-triphosphate pyrophosphohydrolase (8-oxo-dGTPase) in 
male rats given a single sub coetaneous injection of Cd(II) acetate (20 µmol/kg body wt). 8-
Oxo-dGTPase normally prevents DNA incorporation of premutagenic 8-oxo-2'-
deoxyguanosine (8-oxo-dG) derived from a deoxynucleotide pool, damaged by endogenous 
oxidants. Cadmium is also thought to replace metal ions, e.g. copper and iron from metal 
binding proteins, (Fpg) and the mammalian XPA protein (Hartwig et al., 2002a).  Fpg is a 
glycosylase that initiates base excision repair in Eschercihia coli, by recognising and 
removing some oxidative DNA base modifications including 8-oxoG. DNA binding by Fpg is 
mediated by a single zinc finger domain, where zinc is complexed by four cysteins. Asmuss 
and co-workers (Asmuss et al., 2000a; Asmuss et al., 2000b), showed that cadmium inhibited 
Fpg in a dose-dependent manner, and that simultaneous treatment with zinc partly 
counteracted the inhibition. Also XPA contains a four-cysteine single zinc-finger motif which 
is a part of a minimal DNA-binding domain (MBD), and as for Fpg, cadmium strongly 
reduces the binding of XPA to DNA, or to other NER proteins. As a consequence DNA repair 
by NER is weakened. Inhibition of XPA by cadmium is counteracted by simultaneous 
treatment with zinc.  
Taken together, cadmium is a weak mutagenic in itself but may act synergistically when 
cells or organisms are co-exposed to other genotoxic agents. This is a central hypothesis 
studied in the present work  
2.6.5. Induction of apoptosis 
There are several reasons for a cell to commit suicide, via the process known as 
apoptosis. A signal that can lead to apoptosis is DNA damage provoked by toxicants, when 
such lesions are too extensive for recovery by DNA repair mechanisms. In this study we have 
examined the induction levels of a few proteins involved in apoptosis, three of them; p53, p38 
and ERK, and some of their functions are described in this section.  
One of the best known pro-apoptotic proteins is p53, which is an important tumour 
suppressor (Soussi, 2005). p53 function is very often modified in cancers. Exposure of rat 
primary epithelial lung cells (Type 2 and Clara cells) to low levels (1-10 µM) of cadmium has 
been shown to promote apoptosis by inducing p53 and BAX, also a mediator of apoptosis 
(Lag et al., 2002). Further more, the induction of Apoptosis was seen at very low ROS levels 
invariable to antioxidant treatment of the cells, indicating that other than oxidative pathways 
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were involved. Another study by Låg and co-workers (Lag et al., 2005), demonstrated that 
cadmium increased the activity of several proteins such as mitogen activated protein kinases 
(MAPKs); extracellular signal-regulated kinase 1 and 2 (ERK1/ERK2), c-jun N-terminal 
kinase (JNK), protein kinase C (PKC), and p38, in the same rat primary epithelial lung cells. 
It was found that increased levels of p38 induced apoptosis, and some isoforms of PKC were 
probably involved in the promotion of p38 activity. The activation of ERK1 and 2, and JNK 
on the other hand seemed not to be involved in the apoptotic pathway. These findings 
coincide with a study (Chao et al., 2001) which demonstrated that cadmium persistence 
activated ERK and p38 MAPKs in human lung adenocarcinoma cells (CL3 cell line). This 
was observed particularly in the G2/M phase where cadmium induced the highest levels of 
intracellular peroxide and genotoxicity. The activation of ERK and p38 by cadmium was 
associated with increased levels of ROS rather then cadmium accumulation. The authors 
concluded that ERK potentially plays a role in guarding genome integrity, while p38 may 
trigger genome instability and apoptosis in cadmium-treated cells.  
2.6.6. Induction of oncogens 
Cadmium has been shown to interact with various oncogens. The signal transducers c-
jun, c-myc and c-fos are important mediators of cell growth and proliferation, and are linked 
to tumour promotion. The genes encoding them are so called oncogens. Low levels of 
cadmium have been shown to induce c-jun, c-myc and c-fos (Jin et al., 1990;Joseph et al., 
2001). Joseph and co-workers (Joseph et al., 2001) showed that cadmium-induced 
transcriptional activation of the oncogens was linked to elevated intracellular Ca2+ and ROS 
levels. Furthermore, activation of c-jun and c-fos (but not c-myc) was dependent on PKC and 
MAPK pathways in both tumour cells (transformed BALB/c-3T3 cells) and untransformed 
cells (BALB/c-3T3). Similarly, a study conducted on immortalised but untransformed human 
prostate cells (RWPE-1 cells) showed an initial rapid increase in mRNA levels for c-myc, c-
jun and p53, in response to treatment with 10 µM cadmium (Achanzar et al., 2000). While c-
myc and p53 mRNA levels receded after few hours, c-jun levels increased up to 20-fold 
during 24 hours. After 48 hours a substantial increase in apoptosis was seen, but 35 % of the 
cells were viable and appeared normal. The surviving cells had a 2.5-fold increase in cellular 
metallothionein content. From their results the authors proposed that cadmium in this way 
could promote the survival of tumour-prone cells. 
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2.6.7. Disruption of cell adhesion  
Cadmium can disrupt the tight junctions between epithelial cells by interfering with the 
normal function of E-cadherin, a Ca2+-dependent cell adhesion molecule that plays a key role 
in epithelial cell-cell adhesion (Prozialeck et al., 1991; Prozialeck et al., 1997). This is 
thought to occur via displacement of Ca2+ ions in the extra-cellular domains of E-cadherin, 
which leads to a distortion of the protein and loss of adhesive binding to E-cadherin of a 
neighbouring cell. In a review written by Pearson and Prozialeck (Pearson et al., 2001), it is 
suggested that the disruption of E-cadherin plays an essential role in both the initiation of 
cancer by cadmium as well as in tumour promoting effects of cadmium. The assumption is 
that the disruption of E-cadherin could lead to increased transcription of oncogens mediated 
by β-catenin, and that existing cancer cells might more easily detach and invade neighbouring 
tissues (Figure 2.5).   
 
Figure 2.5 The figure shows how Cd2+ is thought to displace Ca2+ in the extra cellular domain of E-cadherin, 
severing the connection between cells. The disruption of E-cadherin is also thought to alter gene expression due 
to translocation of β-catenin to the nucleus, indicating a possible mechanism of cadmium activation of oncogens 
(Pearson et al., 2001). 
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2.6.8. Effects of cadmium on DNA methylation 
Cadmium also interferes with methylation. Methylation of DNA is a vital cellular 
function related to genomic imprinting and regulation of gene transcription, and constitutes an 
important field in cancer research (reviewed by Worm et al., 2002). Generally DNA 
methylation causes gene silencing. Sustained methylation (hypermethylation) of particular 
DNA sequences, e.g. promoter regions of tumour-suppressor genes, can potentially enhance 
the risk of tumour development due to loss of protein production. Similarly, continuous 
repression of DNA methylation (hypomethylation) can result in elevated transcription of 
oncogens, thereby enhancing cancer risk. Both types of defects in DNA methylation have 
been linked to carcinogenesis. In a study by Takiguchi and co-workers (Takiguchi et al., 
2003) performed on rat liver cells, it was shown that cadmium inhibited the enzyme DNA (5-
cytosine) methyltransferase (DNA MeTase), which methylates cytosine residues. In mammals 
the methylation of cytosine residues is the predominant post-replication base modification. It 
was also found that even if cadmium initially inhibited DNA MeTase, prolonged exposure (10 
weeks) to cadmium led to an increased activity of the enzyme, resulting in hypermethylation 
of DNA. The rat liver cells also showed signs of transformation in response to continuous 
cadmium treatment.   
3. Materials and methods 
3.1. Cell culture and treatments 
3.1.1. Cell culture 
The Human Testicular Germ Cell Tumour (TGCT) cell line 833K, is derived from the 
embryonic carcinoma component of a mixed histology testicular germ cell tumour metastasis 
(metastasised, nonseminomatous germ cell tumour) (Bronson et al., 1980). We used 833K as 
a model cell line in our study. The cells are a generous gift from John Master. 
The 833K cells were routinely maintained in RPMI 1640 medium (with L-glutamine and 
phenol red), supplemented with 10 % heat-inactivated Australian calf serum (AS) and 1 % 
Penicillin & Streptomycin (P/S). The cells were grown to confluence (70-80 %) in 162 cm2 
Costar cell culture flasks (Corning Inc.), at 37 °C with 5 % CO2 in air under saturated 
humidity. Cells were passaged using trypsin-EDTA every 3 or 4 days. Passages over 20 were 
discarded and replaced by cells from frozen stock (passage 7) stored in liquid nitrogen. 
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3.2. Cytotoxicity assays 
3.2.1. Determination of cadmium concentration 
We wanted determine the concentration of Cd2+ (CdCl2•2.5H2O) that would trigger 
cellular responses but had little effect on cell viability (Table 3.1). Viability was determined 
by staining the cells with the fluorophores Propidium Iodide (PI) and Hoechst 33342, and then 
examining the cells using a fluorescence microscope. PI intercalates between the bases of 
nucleic acids (RNA as well as DNA) and may be exited either by UV or blue light giving red 
fluorescence. Hoechst 33342 binds preferentially to AT-rich regions in the small groove of 
DNA and fluoresces blue when excited by UV light. Unlike Hoechst 33342, PI is not able to 
pass through intact plasma membranes. So whilst Hoechst 33342 colours all nuclei blue, PI 
will only enter cells which have a disrupted plasma membrane (necrotic and late apoptotic 
cells) and will stain the nuclei red. Early apoptotic cells have intact plasma membranes and 
thus do not allow PI to enter the cells. However apoptotic cells are recognised by distinct 
morphologies (e.g. condensation of cellular compartments, small and spherical apoptotic 
bodies). The cells were divided into three different categories: 1. Viable, 2. Necrotic, 3. 
Apoptotic. 
                                               
                                             Table 3.1 Cell culture treatments. 
Treatment [Cd2+] µM Incubation (h) 
1(Control) 0 20 
2 2.5 20 
3 5 20 
4 10 20 
5 30 20 
6 50 20 
7 200 20 
 
Procedure  
1. Medium with cadmium was prepared by adding freshly made cadmium stock solution 
to medium that contained calf serum.  
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2. 833K cells were plated onto Costar cell culture dishes (28 cm2), 5x105 cells per dish in 
2 ml medium (sub-confluent cell density), and incubated for 4 h to allow cells to 
attach.  
3. After incubation the medium was removed and new medium that contained different 
concentrations of cadmium was applied to the samples. 
4. The cells were incubated for 20 h under standard conditions. 
5. Medium from each sample was transferred to 15 ml Falcon tubes, and the cells were 
washed twice with 2 ml Ca2+ and Mg2+ -free PBS, and detached with 200 µl trypsin-
EDTA. The cells were then added to the medium. 
6. Cell suspensions were briefly centrifuged at 280 x g for 5 min, and the supernate was 
discarded. 
7. Cells were re-suspended in 1 ml fresh medium.  
8. Half (500 µl) of each sample was fixed in an equal volume of 0.2 % para-
formaldehyde for flow cytometric analysis. 
9. The remainder of the samples were given 5 µl of PI (0.5 mg/ml), 5 µl of Hoechst 
33342 (1 mg/ml) and 5 µl of Bovine Serum albumin (BSA) (BSA reduces clumping of 
the cells).  
10. The samples were re-suspended and incubated for 10 min before they were examined 
using a fluorescence microscope. 
3.2.2. Effects of UVC, alone or in combination with cadmium, on 
cell viability 
We wanted to find a UVC dose that would induce cellular responses (such as DNA 
single-strand breaks) in 833K cells pre-incubated with or without 5 µM Cd2+, and at the same 
time had little effect on cell viability. Viability was measured using PI/Hoechst. 
 
                        Table 3.2 Cell culture treatments. 
Treatment [Cd2+] µM UVC (J/m2) Incubation (h) 
1 (Control) 0 0 24 
2 5 0,5 24 
3 5 1 24 
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4 5 3 24 
5 5 5 24 
6 5 10 24 
7 0 0,5 24 
8 0 1 24 
9 0 3 24 
10 0 5 24 
11 0 10 24 
 
Procedure 
1. 833K cells were plated onto Costar cell culture dishes (28 cm2), 5x105 cells per dish in 
2 ml medium, and incubated for 4 h for cell attachment.  
2. After incubation the medium was removed and 2 ml fresh medium with or without 5 
µM cadmium was applied to the samples. 
3. Samples were incubated for 20 h before they were cooled down to ~ 4 °C on 
aluminium plates. 
4. Samples were exposed to different doses of UVC and further incubated for 4 h. 
5. Each sample was processed as described in section 3.2.1 
6. Half of each sample was fixed for flow cytometric analysis, and the remaining half 
were stained with PI and Hoechst for viability count in the fluorescence microscope. 
3.2.3. Flow cytometric analysis of cell cycle stages   
Flow cytometry is a means of measuring certain physical and chemical characteristics of 
cells (or other particles) e.g. cell size, DNA content, shape and internal complexity, as they 
travel in suspension one by one past a sensing point. The flow cytometer consists of a light 
source, collection optics, electronics and a computer to translate signals to data.  
We wished to investigate if cadmium alone and/or UVC treatment had an effect on the 
cell cycle. The cell samples that were fixed with 0.2 % paraformaldehyde, were stained with 
Hoechst 33258, and analysed in an Argus 100 flow cytometer (Skatron, Lier, Norway). The 
percentages of cells in the different phases of the cell cycle were estimated from DNA 
histograms using the Multicycle Program (Phoenix Flow System, San Diego, CA, USA). It is 
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possible to distinguish different cell phases, as well as apoptotic cells/bodies and secondary 
necrotic cells, on the basis of their DNA content (Hoechst 33258 fluorescence) and cell size 
(forward light scatter) (Wiger et al., 1998;Gorczyca et al., 1993). All samples were analysed 
by Richard Wiger at (our) Department of Chemical Toxicology (MIKT), at the Norwegian 
Institute of Public Health. 
3.2.4. Analytic quantification of cadmium in 833K cells 
In order to investigate to what degree cadmium was taken up by the cells, we exposed 
833K cells to two different concentrations of cadmium (5 µM and 10 µM) in medium 
containing calf serum (Table 3.3), where after the content of cadmium in the cells and in the 
medium was analysed by means of atomic absorption spectrometry.  
 
                                    Table 3.3 Cell culture treatments 
Treatment [Cd2+] µM Incubation (h) 
1 (Control) 0 20 
2 5 20 
3 10 20 
 
Procedure 
1. 833K cells were plated onto six Costar cell culture dishes (28 cm2), 5x105 cells per 
dish in 2 ml medium, and incubated for 4 h to allow the cells to attach before the 
medium was changed. 
2. Samples were incubated for 20 h, and transferred to Falcon tubes together with the 
medium.  
3. Samples were centrifuged at 500 x g for 5 min, and the supernates were transferred to 
new Falcon tubes. These tubes were named “wash 1”. 
4. Cell pellets were re-suspended in 2 ml PBS and centrifuged at 500 x g for 5 min. 
Supernates were transferred to new Falcon tubes called “wash 2”. 
5. Cell pellets were re-suspended in 2 ml PBS and centrifuged at 500 x g for 5 min. 
Supernates were transferred to new Falcon tubes, called “wash 3”. 
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6. 2 ml of HNO3 : H2O (1 : 1), was added to each of the “wash” tubes as well as the 
pellets. 
7. All samples were incubated at 90 °C for 1 h. 
8. All volumes were adjusted to 5 ml with deionised water. 
9. Cadmium content was measured by Ewa Andruchow at the Department of Analytical 
Chemistry (MIAN), at the Norwegian Institute of Public Health.  
3.3. DNA repair assays 
3.3.1. DNA alkaline filter elution  
The method is used to quantify DNA damage levels in the form of single strand breaks 
(SSBs). Cells were lysed, the DNA unwound, purified, eluted and collected as two-hour 
fractions in a semi automated setup. DNA contents in the fractions of eluted DNA are 
measured fluorometrically using Hoechst 33258 (excitation max: 360 nm, emission max: 450 
nm) in an automated sampler connected to a recorder and a computer. Hoechst 33258 binds to 
DNA with a strong preference for A-T rich sequences. The resulting peaks from the recorder 
are manually read and then fed to a computer and calculated by software. The data output 
includes total amount of DNA in each sample, summarised from the fractions, and elution 
profiles which are used to calculate DNA damage levels. DNA damage levels are determined 
by the Normalised Area Above (the elution) Curve (NAAC) (Brunborg et al., 1996). 
Calibration of NAAC values is achieved by exposing cells to a known dose of X- rays and 
analysing them by alkaline elution.  
To study the effects of cadmium on DNA repair in 833K cells we combined alkaline 
elution with a crude extract of the enzyme bacteriophage T4 pyrimidine dimer glycosylase 
(T4-pdg), formerly known as T4 endonuclease V (Lloyd, 2005). T4-pdg has a high affinity for 
cyclobutane pyrimidine dimers (CPDs) which is the main type of DNA lesions induced by 
UVC. The enzyme binds to and incises the lesions leaving gaps in the DNA. Consequently if 
cadmium inhibits mechanisms involved in DNA repair of UVC induced lesions, we would 
expect cells co-exposed to cadmium and UVC to show higher levels of DNA damage (NAAC 
values) than cells exposed to UVC only. In an alternative approach we made use of the DNA 
repair inhibitors (RI) Cytosine Arabinoside (AraC) and Hydroxyurea (HU). AraC and HU are 
so called anti-metabolites used in cancer treatment. AraC is metabolised intracellularly into its 
active form; cytosine arabinoside triphosphate (AraCTP). AraCTP inhibits both the initiation 
and elongation steps of DNA synthesis. HU inhibits the enzyme deoxyribonucleotide 
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reductase which synthesises deoxyribonucleotides. In effect the two drugs knock out the 
polymerisation and ligation steps of DNA repair. After cadmium and UVC exposure the cells 
were incubated with the inhibitors before SSBs were measured. Cells co-exposed to cadmium 
and UVC should show a lower NAAC value than cells treated with UVC only, if cadmium 
was to inhibit enzymes involved in the incision step of DNA repair. The alkaline elution 
procedures are based on Brunborg et al. (1988) with some modifications. All cell cultures 
were protected from light during the entire treatment period to avoid additional light-induced 
DNA damage. 
Procedure 
1. 833K cells were plated onto 36 Costar cell culture dishes (28 cm2), 5x105 cells per 
dish in 2 ml medium, and incubated for 4 h for cell attachment.  
2. After incubation the medium was removed and replaced by fresh medium with or 
without 5 µM cadmium, and further incubated for 20 h under standard conditions.  
3. Medium with repair inhibitors (RI) was prepared during the last 15 min of incubation. 
Step 3 does not apply to treatment with T4-pdg. 
4. The cells were cooled to ~ 4 ºC on aluminium plates before exposure to various doses 
of UVC. 
5. When DNA alkaline elution was to be combined with T4-pdg treatment, the cells were 
incubated for 4 h at 37 °C for repair after the UVC treatment. Alternatively the 
samples were given 222 µl of RI solution (final concentration: 0.1 mM AraC, 2mM 
HU per sample), and incubated for 1 h. 
6. Following incubation the samples were kept cold (~ 4 °C), until they were loaded onto 
designated filters in an automated DNA alkaline elution system (Brunborg et al., 
1988). The filters were submerged at all times in a temperature regulated water bath. 
7. Samples were washed with Merchant buffer for 30 min at a flow rate of 0.6 ml/min for 
each filter. Temperature ~ 4 °C. 
8. After the wash with Merchant´s buffer the cells were lysed for 1 h with lysis buffer. 
For the initial 5 min the flow rate was 0.6 ml/min, during which the water temperature 
was quickly increased up to ~ 22 °C. For the remaining 55 min the flow rate was 0.09 
ml/min.  
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9. Lysis buffer was completely washed out with 20 mM Na2EDTA, pH 9.6 for 35 min at 
a flow-rate of 0.25 ml/min.  
10. The samples were washed with BE1 buffer for 1 h at a flow-rate of 0.25 ml/min. Steps 
10 and 11 apply only to the treatment with T4-pdg. 
11. A crude extract of T4-pdg dissolved in BE1 buffer was added. The mix was first 
flushed through each filter (0.25ml/min) for 8 min at 22 ºC, and then 30 min (0.034 
ml/min) at 37ºC.  
12. DNA remaining on the filters was washed with 20 mM Na2EDTA, pH 9.6, for 37 min 
at 22ºC (0.25 ml/min).  
13. DNA was eluted with Elution buffer at a flow rate of 0.03 ml/min, for 16 h, producing 
8 two-hour fractions of eluted DNA for each sample. 
14. Elution buffer (4 ml) was flushed through the system for each sample to produce 
fraction number 9. 
15. Each chamber containing the filters was opened and the filters were incubated in 10 
ml elution buffer and stirred for 45 min in a water bath at 42 °C. These were 
designated fraction 12. 
16. The chambers were filled with elution buffer and flushed twice after 30 min to 
produce fractions 10 and 11. 
17. DNA content in all of the fractions was quantified fluorometrically with Hoechst 
33258. 
18. DNA-damage levels were calculated from the elution profiles. 
3.4. Gene expression analysis  
3.4.1. Cell culture treatment 
The cells were protected from light sources during the entire experiment to avoid 
additional photo-induced DNA damage. The cultures were treated as shown in table 3.4.  
                      Table 3.4 Cell culture treatments 
Treatment [Cd2+] µM UVC J/m2 Incubation (h) 
1 (Control) 0 0 24 
2 5 0 24 
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3 0 3 24 
4 5 3 24 
 
Procedure 
1. 833K cells were plated onto Costar cell culture dishes (78 cm2), 5-6 x106 cells per dish 
in 5 ml medium, and incubated for 4 h to allow the cells to attach. 
2. The medium was removed and replaced by fresh medium with or without 5 µM 
cadmium, and the cells were further incubated for 20 h. 
3. After incubation the cells were cooled down to ~4 °C on aluminium plates, exposed to 
3 J/m2 UVC, and incubated for additional 4 h. 
4. Total-RNA or protein isolation. 
3.4.2. Total RNA isolation  
Isolation was performed according to manufacturer protocol (GenEluteTM Mammalian 
Total RNA Kit). Samples were lysed and homogenised in guanidine thiocyanate and β-
mercaptoethanol (β-ME) to release RNA and inactivate RNases. Lysates were spun through a 
filtration column to remove cellular debris and shear DNA. Next the filtrates were applied to 
high capacity silica columns to bind total RNA, followed by wash and elution.  
Procedure 
1. The β-mercaptoethanol was added to the lysis solution (10 µl β-ME/1 ml lysis 
solution).  
2. Medium was removed from the cell-cultures and the cells were washed twice with 
PBS. 
3. Cells were lysed by adding 500 µl of lysis solution/β-ME mixture directly to each 
sample, covering the whole surface of the dish. 
4. The lysates were transferred to filtration columns provided in the kit, and spun for 2 
min at maximum speed (14000 x g). This step removes cellular debris and shears 
DNA. 
5. An equal volume of 70 % ethanol was added to the filtrates and thoroughly mixed.  
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6. The lysate/ethanol mixtures were transferred to binding columns, and spun for 30 s at 
maximum speed. Flow-through was discarded.  
Wash to remove contaminants 
7. First 500 µl wash solution 1 was added to each column, where after the columns were 
spun for 30 s at maximum speed. Flow-through was discarded. 
8. Likewise 500 µl wash solution 2 was added to each column, and the columns were 
spun for 30 s at maximum speed. Flow-through was discarded. 
9. A second 500 µl wash solution 2 was added to each column, and the columns were 
spun for 30 s at maximum speed. Flow-through was discarded. 
10. Columns were spun for 2 min to remove remaining ethanol. 
Elution of purified RNA 
11. The columns were transferred to new collecting tubes. 
12. A 50 µl of elution solution was added to the columns and the columns were spun for 1 
min at maximum speed. 
13. A second 50 µl of elution solution was added and the columns were spun for 1 min. 
(The second 50 µl were added because more then 50 µg RNA was expected per 
column). 
14. The flow-through containing the RNA was collected and spun through the column a 
second time, to increase the yield of total RNA. 
15. The purified RNA was stored at -70 °C. 
3.4.3. Determining the concentration and purity of isolated total 
RNA  
We used the “NanoDrop ND-1000 spectrophotometer” which is a full-spectrum (220-750 
nm) spectrophotometer that measures 1 µl samples with high accuracy and reproducibility.  
When measuring nucleic acids there are two ratios of importance: 260/280 nm and 
260/230 nm (Figure 3.1). The ratio of absorbance at 260 and 280 nm is used to assess the 
purity of DNA and RNA. A ratio of ~1.8 is generally accepted as “pure” for DNA, whereas a 
ratio of ~2.0 is generally accepted as “pure” for RNA. Ratios appreciably lower in either case 
may indicate the presence of proteins, phenols or other contaminants that absorb strongly at or 
near 280 nm. The ratio of sample absorbance at 260 and 230 nm often have higher values then 
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the respective 260/280. They are commonly in the range of 1.8-2.2. Appreciably lower values 
may indicate the presence of co-purified contaminants. All samples of isolated RNA were 
analysed using NanoDrop. If the concentration of RNA was to low, the sample(s) were 
concentrated using a vacuum-centrifuge. The samples were stored at -70 °C. 
 
 
Figure 3.1 Concentration (ng/µl), 260/280 nm and 260/230 nm ratio-values for isolated RNA (control sample). 
3.4.4. Total-RNA integrity and quality control  
Although NanoDrop provides a good method of assessing the concentration and purity of 
nucleic acids, it says nothing about the integrity of the molecules. In order to ensure that the 
quality of our RNA samples was acceptable we used the “Agilent 2001 Bioanalyzer” and the 
“RNA 6000 Nano LabChip Assay” kit. The method provides a fast and accurate measurement 
of small amounts of RNA. The total-RNA samples are loaded into a 16-well chip that holds a 
separating gel which contains a luminescent dye. 12 samples can be measured per chip. RNA 
in the samples are separated in the gel and analysed by the Bioanalyzer software. The 
resulting data output includes graphs, RNA concentrations, the ratios of 28S rRNA and 18S 
rRNA, and a RNA integrity number (RIN). RIN has a value between 1 and 10 and is 
calculated from the whole area of the graph. RIN = 10 designates RNA of high integrity 
whereas RIN = 1 designates poor integrity. (Figure 3.2 A & B).  
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 Figure 3.2: A) RNA of high integrity, RIN = 10 (control sample). B) Example of degraded RNA. 
Procedure 
(Measurements were performed according to manufacturer protocol. ) 
1. RNA ladder and RNA samples were denatured for 2 min at 70 °C, and equilibrated to 
room temperature for 30 min together with the rest of the reagents. 
2. A 550 µl of gel matrix was filtered through a spin filter for 10 min at ~ 1500 x g. 
3. The dye concentrate was vortexed for 10 s and briefly spun down to collect contents. 
4. A 1 µl of dye concentrate was added to 65 µl of the filtered gel, and the two were 
mixed thoroughly by vortexing. 
5. The gel-dye mix was spun for 10 min at 13000 x g. 
6. The gel was loaded onto the chip according to manufacturer protocol. 
7. A 5 µl of RNA marker was loaded into all wells. 
8. A 1 µl of the RNA ladder was loaded into its designated well and 1 µl of sample was 
loaded into each of the 12 sample wells. The chip was vortexed for 1 min, and run in 
the Bioanalyzer. 
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3.4.5. Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
RT-PCR is a technique used to make complementary DNA (cDNA) from mRNA, and 
then amplifying the cDNA (if needed). Transcribing mRNA into cDNA is termed reverse 
transcription, and is accomplished through the use of a primer that binds to the polyA-tail of 
mRNA and an mRNA-dependent DNA polymerase (Reverse Transcriptase). The resulting 
cDNA strands function as templates for a deoxyoligonucleotide primer and a DNA-dependent 
DNA polymerase. The cDNA is then exponentially amplified via PCR. The original mRNA 
templates are degraded by RNAse. In our study we have not amplified our cDNA, but stopped 
cDNA generation after the first cycle. 
Before cDNA generation was started, all sample parallels of isolated total-RNA were 
pooled together: “control 1” with “control 2 + 3”, “cadmium 1” “with cadmium 2 + 3”, and so 
on. The pooled samples from three parallel experiments were then measured in the NanoDrop 
to determine total RNA content and concentration, and subsequently used to make cDNA. 
Procedure 
(cDNA generation was performed accordingly to the “Fairplay Microarray Labeling Kit” 
protocol from Stratagene.) 
1. A 20 µg of total RNA from each of the pooled samples was suspended in 12 µl 
RNAse free water. 
2. A 1 µl of 500 ng/µl oligonucleotide-dT primer (d(T)12-18 ) was added to each of the 
samples where after they were incubated for 10 min at 70 °C and cooled down on ice. 
Samples were spun briefly to collect content. 
3. The following master mix was prepared (volumes are for one sample) 
 
2 µl of 10x StrataScript reaction buffer 
1 µl of 20x dNTP mix 
1.5 µl of 0.1 M DTT 
0.5 µl of RNAse block (40 U/µl) 
 
4. The master mix was added to the samples 
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5. A 1.5 µl of 50 U/µl StrataScript reverse transcriptase (RT) was added, and the samples 
were incubated for 30 min at 48°C.  
6. Another 1.5 µl of 50 U/µl StrataScript reverse transcriptase was added, and the 
samples were incubated for additional 40 min.  
7. A 10 µl of 1 M NaOH was added and the samples were incubated for 10 min at 70 °C. 
The heating hydrolyses RNA. 
8. Samples were slowly cooled down to room temperature. 
9. A 10 µl 1M HCl was added to neutralise the solutions. 
10. A 4.6 µl of 2.6 M sodium acetate (pH 4.5) was added to each of the samples, as well 
as 1 µl of 20 mg/ml glycogen. 
11. Finally 100 µl of ice cold 95 % ethanol was added, and the samples were stored at -70 
°C.  
3.4.6. Microarray analysis 
As was described in the introduction, DNA and oligonucleotide microarrays are used to 
simultaneously assess the transcriptional states for thousands of genes. Fluorochrome coupled 
cDNA prepared from treated samples and control are hybridised to imprinted gene segments 
on the array. In our study we have used the fluorochromes Cyanine 3 (Cy3) and Cyanine 5 
(Cy5). When scanning the microarrays, Cy3 spots are measured at ~ 532 nm, where as Cy5 
spots are measured at ~ 635 nm. The result of the scanning is actually in greyscale, but the 
scanning software applies pseudo-colours, so that Cy3 is shown in green and Cy5 in red. We 
used the 21k human oligonucleotide microarray v2.3, printed at the Norwegian Microarray 
Consortium (NMC). The microarrays consist of 23.184 spots, including 21.329 oligos (70 
mer) representing 21.329 genes from the UniGene database. The oligos are printed as 48 sub-
grids on the array, each sub-grid printed by a separate print-tip (Figure 3.3). For more details 
on the arrays, we refer to: http://www.mikromatrise.no/facility/Oslo. 
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Figure 3.3 The 21k oligonucleotide microarray v2.3 from NMC 
 
Dye coupling reaction 
Procedure 
(Dye coupling reaction was performed accordingly to the “Fairplay Microarray Labeling 
Kit” protocol from Stratagene.) 
1. The cDNA samples stored in ethanol were spun down at 14,000 x g for 1 h at 4 °C, 
and the ethanol was gently poured out leaving the cDNA pellet attached to the tube 
wall. 
2. The cDNA pellets were washed with 0.5 ml ice cold 70 % ethanol and spun at 14,000 
x g for 30 min at 4 °C. The ethanol was again removed and the samples were briefly 
spun down to collect the last droplets of ethanol, which were removed with a pipette.  
3. The cDNA pellets were air dried to remove residues of ethanol that might interfere 
with the dye coupling reaction. 
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4. The cDNA pellets were re-suspended in 5 µl of 2x coupling buffer, and incubated for 
15 min at 37 °C.  
5. The Cy3(s) and Cy5(s) dyes were re-suspended in 45 µl high purity DMSO, at room 
temperature.  
6. The control sample cDNA was divided into two tubes, 5 µl of Cy3 was added to one 
tube and 5 µl of Cy5 to the other, as well as to the rest of the samples (Cadmium, 
UVC, Cadmium + UVC). 
7. The cDNA-dye mixtures were gently vortexed for a few seconds, and spun down to 
collect contents. 
8. The samples were incubated for 1 h in the dark at room temperature, and gently mixed 
for a few seconds every 15 min.  
Dye-coupled cDNA purification 
9. A 90 µl of 1x TE buffer was added to each of the labelled cDNA samples. 
10. DNA binding solution and 70 % ethanol was mixed together 1 : 1 
11. A 200 µl of the DNA-binding solution and ethanol mixture was added to each of the 
labelled cDNA samples, and mixed by vortexing. 
12. The samples were transferred to microspin cups seated in 2 ml receptacle tubes, and 
spun for 30 s at maximum speed. The flow through containing uncoupled dye was 
discarded. The microspin cups were placed back into the receptacle tubes.  
13. Another 200 µl of the DNA-binding solution and ethanol mixture was added to the 
microspin cups and the samples were spun again for 30 s at maximum speed. Flow 
through was discarded, and the microspin cups were placed back into the receptacle 
tubes. 
14. A 750 µl 75 % ethanol was added to the microspin cups and the samples were spun for 
30 s at maximum speed. Flow through was discarded, and the microspin cups were 
placed back into the receptacle tubes 
15. Second wash with 750 µl 75 % ethanol (previous step repeated). 
16. The samples were spun for 2 min at maximum speed in order to remove all wash 
buffers. The receptacle tubes were discarded and the microspin cups were placed into 
fresh 1.5 ml microcentrifuge tubes. 
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17. A 50 µl of 10 mM Tris base, pH 8.5 was added directly on top of the fibre matrix at 
the bottom of the microspin cups, and the samples were incubated for 5 min at room 
temperature. 
18. The tubes were spun for 30 s at maximum speed. 
19. Additional labelled cDNA was eluted by loading the flow through back onto the fibre 
matrix, incubating the samples for another 5 min, and spinning them for 30 s at 
maximum speed   
20. A final elution was performed by repeating the last elution step.  
Analysis of fluorescence-labelled cDNA with NanoDrop ND-1000 
The NanoDrop ND-1000 includes a module for microarrays which is used to measure 
dye incorporation, concentration and purity of nucleic acid. Nucleic acids are measured at 260 
nm, Cy3 at 550 nm, and Cy5 at 650 nm. The NanoDrop calculates the amount of cDNA 
produced (ng/µl) and pmol of dye incorporated (pmol/µl of Cy3 and Cy5). The control sample 
was measured in the NanoDrop to determine Cy3 incorporation, cDNA and Cy3 
concentration, while the rest of the samples were measured to determine Cy5 incorporation, 
cDNA and Cy5 concentration. Total amount of dye incorporated was calculated by 
multiplying the concentration (pmol/µl) Cy3 or Cy5 with the total volume of the eluted cDNA 
for each sample. The control sample was added to each of the other samples in appropriate 
volumes so that the ratio of Cy3 and Cy5 labelled cDNA was acceptable. The combined 
samples were measured again in the NanoDrop, before hybridisation to the microarrays 
(Table 3.5). 
 
       Table 3.5 Dye incorporation and hybridisations 
Cell treatment Dye incorporated                       Hybridisations 
Control Cy3    
Control* Cy5 Control vs. Control* 
Cadmium Cy5 Control vs. cadmium 
UVC Cy5 Control vs. UVC 
Cadmium + UVC Cy5 Control vs. Cadmium + UVC 
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Oligo array pre-hybridisation 
Pre-hybridisation solution contains a large excess of Bovine Serum Albumin (BSA), 
which physically binds to reactive groups on the surface of the microarray slides, rendering 
them inactive (physical blocking). Physical blocking prevents unbound DNA in printed 
elements associating with the reactive groups on the slide surface, which would otherwise 
lead to elevated background and “streaking” or “comet-tailing” on the slide. 
21. Four 50 ml Falcon tubes, one for each array, filled with pre-hybridisation solution 
were heated to 42 °C in a water bath for 30 min, to ensure that all solids were 
dissolved. 
22. The arrays were incubated in the tubes for 1 h at 42 °C to block the slide surfaces.  
23. After blocking, the arrays were washed twice by quickly placing them in Falcon tubes 
filled with sterile water, and rinsed by agitating the tubes for 30 s. The wash was then 
repeated in new Falcon tubes with sterile water. 
24. The arrays were quickly immersed in Falcon tubes with iso-propanol and agitated for 
30 s. 
25. The arrays were dried in Falcon tubes by centrifugation (480 x g for 5 min), after 
which they were ready for hybridisation. 
Manual hybridisation 
26. The labelled cDNA samples were mixed with hybridisation solution and heated for 3-
5 min at 100 °C, and then cooled down to 48 °C. 
27. The samples were quickly centrifuged to spin down contents, and incubated further at 
48 °C until hybridisation. 
28. The samples were applied onto the gasket slides of the microarrays, already mounted 
in the hybridisation chamber bases.  
29. The microarray slides were gently lowered onto the gasket slides, and the chamber 
covers were placed on top. The chambers were closed and tightened by using the 
chamber clamp. 
30. The flow of the hybridisation solution was inspected by slowly rotating the chambers. 
It is important to ensure a continuous flow of the solution and to avoid stationary 
bubbles.  
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31. The chambers were placed in an incubator at 50 °C were they slowly rotated for 16-17 
h. 
Post hybridisation wash 
32. For each array 3 x 50 ml Falcon tubes were filled with wash solution 1 and heated to 
48 °C in a water bath for minimum 30 min.  
33. After dismantling the hybridisation chambers the arrays were quickly transferred to 
the Falcon tubes containing wash solution 1, and gently agitated until the gasket slides 
let go of the arrays. 
34. The arrays were placed in the second Falcon tubes with wash solution 1 and incubated 
in the water bath for 5 min at 48 °C. 
35. The arrays were quickly transferred to the third Falcon tubes and the previous wash 
step was repeated. 
36. The arrays were transferred to Falcon tubes (wrapped in tin foil to avoid photo 
bleaching of the arrays), with wash solution 2 and gently agitated for 1 min in a rotator 
at room temperature. 
37. Second wash with wash solution 2, (previous step repeated). 
38. In the same manner the arrays were washed in wash solution 3 for 1 min in the rotator. 
39. Incubation in new Falcon tubes with wash solution 3 for 1 min, no agitation.  
40. The arrays were briefly dipped in a Falcon tube containing sterile water before they 
were dried by centrifugation at 480 x g for 5 min. 
3.4.7. Scanning and data processing 
The slides were scanned by an Agilent microarray scanner (Agilent, Inc.) at the 
Norwegian Radium Hospital. The GenePix 4.1 image analysis software (Axon Instruments, 
Inc., Union City, CA) was used for spot segmentation, intensity calculation and flagging spots 
with inadequate measurements. Raw-data results from the GenePix 4.1 image analysis 
software were normalised using print-tip LOWESS, and dye-normalisation by DNMAD 
(http:// damad.bioinfo.cnio.es/). The normalised data was then further processed by GEPAS 
(Gene Expression Pattern Analysis Suite v1.1), filtering out flagged spots, removing 
inconsistent replicates, merging replicates, calculating missing values and removing missing 
values (this option is intended for removing the patterns with many missing values. For 
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example, if you have a dataset with 10 conditions and you set up the minimum percentage of 
existing values to 70 %, all the patterns with less than 7 existing values will be removed, i.e. 
all the patterns with more than 3 missing values will be removed). The methods of 
normalisation will be further explained together with the results. 
3.5. Protein related methods  
3.5.1. Cell treatment  
The cells were plated and treated simultaneously with the cells used for total RNA 
isolation in section 3.4. 
3.5.2. Protein extraction 
Procedure 
All samples were kept cold during the procedure to avoid protein degradation 
1. The medium was removed and the cadmium and/or UVC treated cell cultures were 
washed twice with 5 ml PBS (with Ca2+/Mg2+). 
2. A 500 µl of lysis-buffer was added to each of the 78.5 cm2 cell culture dishes. 
3. The cell culture dishes were scraped and the cell lysates transferred to 15 ml Falcon-
tubes, and put on ice for 10 min.  
4. The cell lysates were sonicated on ice at amplitude 40, using approximately one pulse 
per second, 3 x 10 pulses with 5 s intervals.  
5. A 20 µl of each cell lysate was put aside for measuring protein concentration.  
6. All cell lysates were “snap-frozen” in liquid nitrogen and stored at –70 °C. 
3.5.3. Measurement of protein concentration with the Bio-Rad DC 
Protein Assay 
The reaction is similar to the Lowry assay, and is based on the reaction of protein with an 
alkaline copper tartrate solution and Folin reagent. As with the Lowry assay there are two 
steps which lead to colour development: The reaction between protein and copper in an 
alkaline medium (reagent A), and the subsequent reduction of Folin reagent (reagent B), by 
the copper-treated protein. Colour development is primary due to the amino acids Tyrosine 
and Tryptophan, and to a lesser extent, cystine, cysteine, and histidine. Proteins effect a 
reduction of the Foline reagent by loss of 1, 2 or 3 oxygen atoms, thereby producing one or 
more of several possible reduced species which have a characteristic blue colour with 
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maximum absorbance at 750 nm and a minimum absorbance at 405 nm (Description from 
manufacturer manual. www.bio-rad.com). Bovine serum albumin (BSA) dissolved in lysis 
solution was used to make protein standards.  
Procedure 
1. Five different standards were made from a Bovine Serum Albumin (BSA) solution (1 
mg/ml): 0, 0.25, 0.5, 1.0, and 2.0 µg/µl.  
2. Each of the previously prepared cell lysates were diluted into two different 
concentrations 1/5 and 1/15 of stock. 
3. A 5 µl of each of the diluted protein lysates and standards were loaded into wells on a 
96 well micro-titre plate, three parallels were made for each lysate and standard. 
4. Each of the wells were given 25 µl reagent A' (1ml reagent A + 20 µl reagent S 
(SDS)), and 200 µl of reagent B. 
5. The plate was incubated for minimum 20 min at 37 °C to allow full colour 
development. 
6. Absorption was measured in a plate-reader (Magellan V.1.11, Sunrise) at 750nm. 
7. Protein concentration in the lysates was calculated from the standards, and adjusted 
with lysis buffer to 2.5 µg/µl. 
3.5.4. Protein analysis (Western blot analysis) 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) followed by electroblotting and 
immunodetection, was used to separate and measure concentrations of specific proteins in our 
prepared cell lysates. The method can be used to study protein modifications, how protein 
levels differ in different cells and tissues, and how these levels are affected by certain 
exposures. Effects on protein levels might also suggest modes of action caused by the 
exposure in question. Protein samples of equal concentration are loaded onto the SDS-
polyacrylamide gel, which will separate the proteins according to size during electrophoresis. 
The separated proteins are then transferred onto a nitro-cellulose membrane by 
electroblotting. Next the protein of interest is tagged with a primary antibody which binds to 
protein specific epitopes. A secondary antibody conjugated to horseradish peroxidase (HRP) 
is used to connect to the primary antibody. Finally the protein is visualised through 
chemiluminescence by treating the nitro-cellulose membrane with a solution that contains a 
chemiluminescent substrate which, when activated by HRP, emits light. The emitted light can 
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be detected on film (Figure 3.4), or in a chemiluminescent imager system. Before the 
electrophoresis was started, we added Bromo Phenol Blue (BPB) to the protein lysates (25 µl 
for each millilitre of lysate). BPB makes it possible to follow the buffer front through the gel 
during electrophoresis. We also added β-mercaptoethanol (β-ME) to each of the lysates (final 
concentration 5 %) before they were boiled at 95-98 °C for 4 min and cooled down to room 
temperature. β-ME together with the heating disrupts disulfide bonds, denatures and elongates 
the protein chains. This allows the SDS (Sodium Dodecyl Sulphate) to bind evenly to the 
proteins giving them a uniform negative charge. Consequently the proteins are separated in 
the gel according to size. 
 
Figure 3.4 Photo development by chemiluminescence. 
 
Procedure 
Preparation of the SDS-PAGE gel 
1. Two glass plates were mounted together with spacers between them on a gel-holder.  
2. A well-comb was put between the two glass plates, and a line approximately 1 cm 
under the comb was drawn to mark the starting point of the separating gel. 
3. Freshly made liquid SDS-acrylamide separating gel (6, 10 or 12 %) was poured 
between the two glass plates up to the drawn line. 
4. Water saturated n-butanol was poured on top of the gel to prevent oxygenation and 
even-out the gel surface, and the gel was left to harden for approximately 1/2 h. 
5. The n-butanol was thoroughly washed off with water.  
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6. Freshly made liquid SDS-acrylamide stacking gel (4%) was poured on the top of the 
separating gel and the well-comb was put in place to make 15 loading wells. The gel 
was hardened for approximately 1/2 h.  
7. The gel was placed in a chamber filled with electrophoreses buffer and was now ready 
to separate the protein samples. 
Loading the samples 
8. A 10 µl of molecular weight marker (Precision Plus ProteinTM standards, 
KaleidoscopeTM. BIO-RAD) was loaded into the first well of the gel while the rest 
were loaded with 10 µl (25 µg protein) from each sample.  
Electrophoreses 
9. Electrophoreses was first run at 30 mAmp (per gel) until the samples had moved into 
the separating gel, after which the current was raised to 40 mAmp. Electrophoreses 
was stopped when the BPB was run out of the gel, or when separation of the molecular 
weight marker was satisfactory. 
Electroblotting  
10. Following electrophoreses the glass plates were removed and the separating gel was 
placed in 1x transfer buffer for 15-20 min to avoid the gel from shrinking during 
transfer to the nitro-cellulose membrane. 
11. The gel was placed in an electroblotting-cassette submerged in transfer buffer, and run 
for 1 h at 100 Volt. The cassette was kept cold until protein transfer was complete.  
12. After the run, the cassette was disassembled and the nitro-cellulose membrane was 
washed in 1x TBS for 15 min on a platform shaker. 
Immunological detection of proteins  
13. The nitro-cellulose membrane was incubated in blocking solution (5 % non-fat dry 
milk in 1x TBS) for 1 h on a platform shaker to avoid non-specific binding of 
antibodies to “sticky sites”. 
14. Excess blocking solution was washed of with 1x 10 min in TBST with 1 % non-fat dry 
milk and 0.01 % Thimerosal. 
15. The membrane was incubated over night with primary antibody (Table 3.6) in 10 ml 
1x TBST with 1 % dry milk and 0.01% thimerosal, on a platform shaker at 4ºC. 
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16. The membrane was washed 4 x 10 min in 1x TBST, and incubated with secondary 
antibody (Table 3.7) in 20 ml TBST with 1 % dry milk and 0.01 % thimerosal, for 1 h 
on a platform shaker at room temperature. 
17. Excess antibodies were removed by 3 x 10 min wash with 1x TBST and 1x 10 min in 
1x TBS, where the membrane remained, until used for visualisation by photo 
development. 
 
          Table 3.6 List of primary antibodies 
Antigen Host Dilution Manufacturer 
DDB2 Goat 1 : 2000 Santa Cruz 
XPA mouse 1 : 2000 Santa Cruz 
XPC mouse 1 : 3000 Abcam 
ERCC1 mouse 1 : 20000 Neomarkers 
PCNA mouse 1 : 40000 Abcam 
Cdk2 rabbit 1 : 5000 Santa Cruz 
phospho-Erk (Thr 202, Tyr 204) mouse 1 : 5000 Cell Signalling tech. 
p38 rabbit 1 : 1000 Cell Signalling tech. 
phospho-p38 (Thr 180, Tyr 204) rabbit 1 : 1000 Cell Signalling tech. 
p53 rabbit 1 : 5000 Cell Signalling tech. 
phospho-p53 (Ser 15) rabbit 1 : 3000 Cell Signalling tech. 
MGMT mouse 1 : 5000 Neomarkers 
PARP mouse 1 : 150000 Clontech 
GAPDH mouse 1 : 200000 Biogenesis 
 
       Table 3.7 List of secondary antibodies 
Antigen Specificity Conjugate Host Dilution Manufacturer 
IgG mouse HRP donkey 1 : 40000 Jackson 
IgG rabbit HRP donkey 1 : 100000 Jackson 
IgG goat HRP rabbit 1 : 80000 Zymed 
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Chemiluminescence visualisation 
The following steps are done in a darkroom for photo development. 
18. Equal volumes (2ml) of two chemiluminescent solutions (Pierce, supersignal West 
Dura Extended Duration substrate, reagents) were mixed together. 
19. The membrane was bathed in the combined solution for 5 min and placed between two 
transparent plastic sheets in a photo-developing cassette, the protein side of the 
membrane facing up. 
20. An X-ray film (Fuji Medical X-ray Film, Super RX), was placed on top of the plastic 
sheets with the membrane, and the cassette was closed. The exposure of the film 
varied from 30 s up to 15 min, depending on the intensity of emitted fluorescence 
from the protein-bands. 
21. The film was developed in developing solution for 5 min, rinsed in water for 1 min, 
and fixed in fixer solution for 5 min, washed again with water and finally dried. 
22. The film was scanned and visually analysed. 
3.5.5. Protein sample quality and uniformity control 
To ensure that the extracted protein samples were not degraded and had uniform 
concentrations, each of the protein samples were separated by SDS-PAGE and visualised by 
staining the protein bands with Coomassie Brilliant Blue.  
Procedure 
1. After step 9 in the procedure above, the gels to be inspected were placed in Coomassie 
Brilliant Blue solution over-night. 
2. The following day the gel was first placed in destain solution I, which removes the 
bulk of excess colour, and slowly agitated for 30 min. 
3. The destain solution I was removed and replaced with destain solution II. Destain 
solution II was periodically changed until the gel background became clear. 
4. The gel was dried on a filter in a combined vacuum and heater element. 
5. Conformation of protein bands and uniformity between samples was visually 
determined. 
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4. Results 
4.1. Cytotoxicity assays 
We wanted to determine a cadmium concentration and a UVC dose which only slightly 
affected cell viability, to be used in the DNA-repair and gene-expression studies. 
4.1.1. Determination of cadmium concentration 
A dose – response experiment was performed in which 833K cells were treated with 
various concentrations of cadmium for 20 hours, whereupon the viability of the cells was 
determined using PI/Hoechst. 
More than 90 % of the cells treated with 2.5, 5 or 10 µM Cd2+, were viable. Cells treated 
with 30 or 50 µM Cd2+ showed a ~ 15 % reduction in number of viable cells, where as all the 
cells treated with 200 µM died (Figure 4.1).  
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Figure 4.1 Viability of 833K cells exposed to various concentrations of cadmium. 
4.1.2. Effects of UVC, alone or in combination with cadmium, on 
cell viability 
The 833K cells were co-exposed to 5 µM Cd2+ (24 h) and various doses of UVC or UVC 
alone, whereupon viability of the cells was measured using PI/Hoechst. No apparent 
differences in viability were observed between UVC-treated and co-exposed cells. Both 
groups showed a marked decline in viable cells when exposed to 3 J/m2 UVC or higher 
(Figure 4.2). 
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Figure 4.2 Viability of 833K cells after co-exposure to cadmium and UVC. 
4.1.3. Flow cytometric analysis of cell cycle stages   
Cell samples from all treatments were analysed using flow cytometry, to investigate if 
the percentage distribution of cells in different cell-cycle stages had been altered by the 
various treatments. No consistent differences were observed between the treated samples and 
control when comparing G1, S or G2 phases (Figure 4.3). 
 
Figure 4.3 Flow data from six differently treated cell populations. No apparent treatment related effects were 
observed. 
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4.1.4. Analytical quantification of cadmium in 833K cells 
Approximately one half million cells were incubated in medium containing 5 or 10 µM Cd2+ 
for 20 hours. For analysis by atomic absorption the cells were centrifuged and washed three 
times. In both treatments 96 % of the Cd2+ remained in the medium and wash solutions, while 
4 % was taken up by the cells. Mean amount of cadmium measured in the pellet of cells 
treated with 10 µM Cd2+, was roughly twofold compared to cells treated with 5 µM Cd2+. In 
both cases the levels of cadmium were considerably higher (47-78 fold) than in control cells. 
Thus, cellular uptake of cadmium was directly related to the concentration in the medium 
(Table 4.1).  
                                  Table 4.1 Cadmium uptake in 833K cells. 
 
 
 
 
 
 
 
 
4.2. DNA repair assays 
4.2.1. DNA alkaline elution combined with AraC and HU 
To investigate if cadmium could inhibit the initial steps of DNA repair we blocked DNA- 
synthesis with the inhibitors AraC and HU. The results show no statistically significant 
differences between cells co-exposed to cadmium and UVC and cells exposed to UVC only 
(Figure 4.4).  
Sample Fraction Mean amount of Cd2+ (µg) 
Control Cell Pellet 1.435 x 10-3 
 Total 2.945 x 10-3 
5 µM Cell pellet 0.0715 
 Total 1.773 
10 µM Cell pellet 0.110 
 Total 2.977 
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Figure 4.4 Results from one representative experiment. 833K cells were grown with or without 5 µM cadmium 
before exposure to different doses of UVC. All samples were then incubated for 1 hour in the presence of RI 
before DNA damage levels were measured by alkaline elution. 
4.2.2. DNA alkaline elution combined with T4-pdg treatment 
To study the effect of cadmium on DNA repair efficiency we pre-incubated 833K cells 
with or without 5 µM Cd2+ before DNA lesions were induced by UVC (1 J/m2) irradiation. 
The cells were further incubated for repair where after DNA damage levels were measured by 
alkaline elution combined with T4-pdg. The results show a significantly (two-tailed t-test, p ≤ 
0.01) lower repair of UVC induced DNA lesions in the samples grown in the presence of 
cadmium, after three hours. After six hours the difference is still visible but not statistically 
significant (two-tailed t-test p ≤ 0.08), (Figure 4.5).  
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Figure 4.5 Results from one representative experiment. The cells were grown in medium either with or without 5 
µM Cd2+ followed by exposure to UVC (1 J/m2) and incubated 3 or 6 hours for repair. DNA-damage levels were 
then measured by DNA alkaline elution incorporating T4-pdg. 
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4.3. Gene expression analysis 
4.3.1. Total-RNA purity and quality control 
In order to get successful microarray hybridisations it is crucial that the RNA used is of 
high quality. Purity and integrity of our total-RNA samples was assessed using the NanoDrop 
ND-1000 spectrophotometer and the Agilent 2001 Bioanalyzer, respectively. The results of 
the analysis are listed in Table 4.2 and Figure 4.6, which show sample absorbance ratios 
(260/280 nm & 260/230 nm), rRNA ratio (28s/18s) and RIN values. The ratio of sample 
absorbance at 260 and 230 nm should ideally lie in the range 1.8-2.2, which indicates the 
presence of some co-purified contaminants in our samples. However, both the ratio of sample 
absorbance at 260 and 280, and the high RIN values show that the samples are of good 
quality.  
 
Table 4.2 Purity and integrity of total-RNA samples 
 
 
Sample Mean 260/280 St.dev +/- Mean 260/230 St.dev +/- (28s/18s) RIN 
Control 2.08 0.007 1.75 0.163 2.5 10 
Cadmium 2.06 0.028 1.70 0.092 2.6 10 
UVC 2.07 0.014 1.45 0.318 2.6 10 
Cadmium + UVC 2.09 0.014 1.59 0.318 2.3 10 
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Figure 4.6 The graphs are well defined with distinct 28s and 18s peaks, signifying RNA of high quality.  
4.4. Microarray analysis 
Out of the twelve 21k oligonucleotide microarrays used we achieved eight hybridisations 
of acceptable quality that were further processed.   
4.4.1. Results of normalisation 
Essentially, the objective of the normalisation is to adjust for effects that are due to 
variations in the technology rather than the biology. In particular for differences in the red and 
green intensities caused, for example, by differences in the binding of the dyes (i.e., dye 
biases). Since these differences can be related to which print-tip printed each spot (when 
producing the array), the adjustment is carried out, generally, for each print-tip separately. 
Thus, the basic normalisation is based on a print-tip Lowess, which fits a robust local 
regression to the relation between M (difference in log ratios) and A (the "average" staining). 
The normalised M value is the original one minus the Lowess fitted one, and thus should 
correct for spatial effects (as reflected by print-tips) and for effects related to intensity.  
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MA plots 
The MA plots show the relationship between A (the "average signal" [0.5 * (log R + log 
G)], where R is the background subtracted red [mean of F635 - median of B635] and G the 
background subtracted green [mean of F532 - median of B532]) and M (the log [base 2] 
differential ratio: log(R/G)). These plots are shown both before and after normalisation, and 
with different colour lines for the Lowess lines of each print-tip (Figure 4.7). 
 
 
Figure 4.7 The figure shows results of MA plots for control vs. cadmium/UVC. 
Diagnostic plots 
First plots shown are log2 histograms of the raw intensities of each of the foreground 
channels. Similar information is also displayed in the density plots of the arrays. The densities 
shown are for the raw green and red channels (shown as red and blue, respectively). On the 
left, and for comparison, is the distribution of these channels for all the arrays. The image 
plots, displays the quality of the arrays and possible spatial problems. The image plots of the 
log2 intensities of the foreground and background are shown for both channels, as well as the 
un-normalised and normalised M values (the log [base 2] differential ratio: log(R/G)) (Figure 
4.8).  
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Figure 4.8 Diagnostic plots for control vs. cadmium/UVC. 
Box plots 
The box plots show the log intensities before and after normalisation for the 48 print-tips 
used to print each sub-grid on the array (Figure 4.9). This allows us to assess the quality of 
each sub-grid and remove, if necessary, those grids that deviate strongly before normalisation.   
 
Figure 4.9 Each of the box-plots represents 1 of 48 tips used to print the oligos onto the array.  
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4.4.2. Finding differentially expressed gene profiles   
We started out with ~21 000 genes per array, and after the above mentioned processing we 
ended up with ~11000 complete gene patterns. In order to find differentially expressed genes 
between the treatment groups, the genes were clustered by K-means and Hierarchical 
clustering, using J-express Pro 2.6 (www.molmine.com) (Figure 4.10, 4.11a-c and 4.12).  
 
 
Figure 4.10 Each individual gene out of the 11 000 is sorted into a cluster that contains genes with resemblance 
to each other in terms of expression profile.   
 
 60 
 
Figure 4.11a. Left upper diagram 463 genes, left lower diagram 330 genes. Total of 793 differentially expressed 
genes specific to treatment with cadmium. 
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Figure 4.11b. Left upper diagram 340 genes, left lower diagram 300 genes. Total of 640 differentially expressed 
genes specific to treatment with UVC. 
 
 
 
Figure 4.11c. Left diagram 92 genes, right diagram 31 genes. Total of 123 differentially expressed genes 
specific to treatment with both cadmium and UVC. 
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Figure 4.12 Column 1: Control, 2: Cadmium, 3: UVC, 4: Cadmium + UVC. The figure shows genes that are up-
regulated in treated groups, but also genes less affected to cadmium alone (marked segment). 
4.4.2.1. Gene annotation 
Those genes that displayed differentiated patterns of expression were annotated and 
functionally categorised by GENETOOLS (http://www.genetools.microarray.ntnu.no/adb/). 
GENETOOLS is a collection of web-based tools on top of a database that brings together 
information from a broad range of resources, and provides this in a manner particularly useful 
for genome-wide analyses. Today, the two main tools connected to this database are the; 
NMC Annotation Database V2.0 and eGOn V2.0 (explore Gene Ontology). eGOn is a tool 
that facilitates use of biological background knowledge in analysis of genes selected from 
high throughput analysis like e.g microarray analysis. Lists of identifiers containing i.e. 
differentially expressed genes, are submitted to the annotation database, and eGOn 
automatically extends the list with Gene Ontology (GO) terms annotated to these genes.  
4.4.2.2. Enriched genes 
Having identified the genes, we selected those exhibiting the most noticeable changes in 
expression within each treatment group and exported these to a excel spreadsheet. For 
cadmium treated cells we found a total of 380 genes that were enriched (up- or down 
regulated) compared to control, likewise 188 genes for UVC treated cells, and 76 genes for 
cadmium and UVC co-treated cells (Table 4.3). P-values were calculated for the number of 
genes that were enriched due to UVC, or cadmium and UVC co-treatment, compared to cells 
treated with cadmium alone.  For instance, our results show that 11 genes involved in cell 
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cycle were significantly (p = 0.034) enriched in cells co-treated with cadmium and UVC, 
while the 20 genes represented by UVC were not (p = 0.093). Similarly our results show that 
14 genes involved in cellular catabolism were significantly (p < 0.001) enriched in cells 
treated with UVC alone, where as cadmium and UVC co-treated cells are represented by only 
one gene that is not significantly enriched (p = 0.437). The results show that 833K cells pre-
treated with cadmium before UVC exposure, differ in expression of several genes compared 
to cells exposed to UVC alone.  
 
Table 4.3 Genes are sorted into their respective categories of biological function, and the 
number of genes in each category is displayed for each treatment group. P-values assess the 
statistical significance of enriched genes for the groups.   
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4.5. 3.6 Western blot analysis 
All results concerning Western analysis are derived from a preliminary screening for 
proteins associated with UVC and/or cadmium exposure, and must be recognised as such. 
Consequently there are a limited number of parallels to collaborate the results. Protein levels 
of the house-keeping protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH), was used 
as a loading control, when possible (Data not shown).  
Coomassie Blue staining confirmed that the protein concentration in the samples was 
relatively uniform, and that the proteins were intact (Figure 4.13). Degraded protein would 
have produced a continuous smear running down each well in stead of bands.  
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Figure 4.13 The protein bands are well defined suggesting that protein integrity is good. Concentrations appear 
to be of similar strength in the samples. 
4.5.1. Proteins associated with DNA damage repair  
Both XPC and UV-DDB are needed for DNA damage recognition in global genome 
repair of the NER pathway.  Our results showed a lower expression of XPC in cells exposed 
to UVC, indifferent of cadmium pre-treatment. As for DDB2 (subunit of UV-DDB); there 
seemed to be a slightly higher induction in the sample from cadmium treated cells compared 
to the other (Figure 4.14 a-b). XPA and ERCC1 play crucial roles in confirming correct 
assembly of the NER complex, and incising the DNA damage. There was a slightly higher 
induction of XPA in cells exposed to UVC, ignoring cadmium pre-treatment, whereas the 
same treatments showed a reduction in ERCC1 (Figure 4.14 c-d). Proliferating Cell Nuclear 
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Antigen (PCNA), also called polymerase delta auxiliary protein (because of its function as co-
factor in polymerase δ), is involved in replication and in both NER and BER. We found that 
PCNA was strongly and evenly expressed in all the samples (Figure 4.14 e). PARP: Poly 
(ADP-ribosyl)ation is a radical means of post-translational modification of proteins in 
Eukaryotic cells, and is preformed by enzymes called poly(ADP-ribose) polymerases 
(PARPs). PARPs are involved in a great many biological processes, including DNA repair 
(especially BER) and maintenance of genomic stability, transcriptional regulation, centromere 
function and mitotic spindle formation, apoptosis and necrosis. In the occurrence of DNA 
strand breaks, PARP activity can increase over a 100 fold in cells (Burkle, 2005). 
Furthermore, PARP is cleaved during apoptosis giving rise to a protein (subunit) of 85 kD. 
Our results showed a clear expression of PARP in all of the treated cell groups as well as 
control. Moreover, both UVC-treated cells and Cd2+ + UVC-treated cells displayed the 
additional lower band which is often produced during apoptosis (Figure 4.14 f). Finally we 
assessed the expression of O6-Methylguanine-DNA Methyltransferase (MGMT). MGMT 
removes highly mutagenic lesions caused by alkylation of guanine at the O6-position. MGMT 
is called a “suicide protein”, because it transfers the methyl or other alkyl groups bound in the 
O6-position of guanine to a cysteine residue within its active site. The alkyl group is 
irreversibly bound to MGMT, leaving the protein functionally inactive (Srivenugopal et al., 
1996). The expression of MGMT seemed to be particularly low in the cells co-exposed to 
Cd2+ and UVC, compared to the other samples (Figure 4.14 g).  
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Figure 4.14 a-g. Proteins involved in DNA damage repair. 
4.5.2. Proteins related to cell cycle control and apoptosis 
The p53 protein functions as a master switch that coordinates and concentrates a plethora 
of stress signals and transforms them into a series of responses, such as arrest of cell growth, 
apoptosis or DNA repair (Soussi, 2005). Our results showed an induction of p53 protein 
levels in 833K cells exposed to UVC with or without cadmium pre-treatment. In contrast p53 
phosphorylated at serine15 [phospho-p53(ser15)], was strongly induced and visible only in 
833K cells pre-treated with cadmium, independent of UVC exposure (Figure 4.15 a-b). Cyclin 
Dependent Kinase 2 (Cdk2), when associated with cyclin E, is a mediator of cell transition 
from G1 to S phase through phosphorylation of a restricted number of proteins, including the 
tumour suppressor protein Retinoblastoma (Rb). Cdk2 also mediates cell transition from S to 
G2 phase, but then in association with cyclin A (Malumbres et al., 2005). The active form of 
Cdk2 is phosphorylated, which makes the protein appear as a dual band in the gel (un-
phosphorylated/phosphorylated). Our results showed reduced levels of Cdk2 in the cells 
treated with UVC, the lowest levels seen in co-exposed cells, but also a slight induction in the 
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cells treated to cadmium alone (Figure 4.15 c). Erk and p38 are both kinases that initiate 
Mitogen Activated Protein kinase (MAPK)-cascades vital to cell growth, differentiation, and 
apoptosis. Erk is generally activated by growth factors and initiates cascades required for cell 
survival and proliferation, whereas p38 is typically induced by genotoxic agents e.g. 
cadmium, and activates MAPK pathways involved in cell cycle arrest and apoptosis (Chao et 
al., 2001;Lag et al., 2005; Miguel et al., 2005). Activation of signal mediators (i.e. Erk and 
p38) is often achieved by phosphorylation; we therefore measured the expression of phospho-
Erk, p38 and phospho-p38. All three treatments increased the levels of phospho-Erk 
compared to control; the strongest induction seen in cells treated with cadmium (Figure 4.15 
d). As for both p38 and phospho-p38 the induction levels displayed no differences between 
the samples (Figure 4.15 e-f). 
 
 Figure 4.15 a-f. Regulators of cell cycle, growth and apoptosis. 
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5. Discussion 
In this study we have combine traditional toxicological in vitro tests with modern 
microarray technology, in an attempt to assess the effects of co-exposures to harmful agents in 
biological systems. We chose cadmium and UVC as model agents because of their well 
documented genotoxic properties, and because they represent agents that may – based on their 
mechanism of action - exert synergistic toxic effects. 
5.1. Cell culture 
We have used the human TGCT cell line 833K derived from metastasised testicular 
tumour cells as a model cell line in our study. The 833K cells exhibit rapid growth and 
proliferation, and are known to have functional nucleotide excision repair. Considering that 
cancer cells generally have abnormal cellular functions, such as irregular transcription of 
genes leading to gain and/or loss of important protein functions, it could be argued that an 
untransformed cell line would have served as a better model. Normal cells would for instance 
display normal gene transcription, cell cycle progression and arrest, induction of apoptosis, 
etc. However, bearing in mind that the feasibility of the exploratory approach was more 
important then the results of exposure per se, we felt that the type of cell line used played a 
minor role.  
5.2. Exposure of cells 
Based on the viability of 833K cells using Propidium Iodide and Hoechst 33342, we 
determined the cadmium concentration and the UVC doses to be used in the DNA-repair 
assays and the gene-expression analysis. All treatments were performed in medium that 
contained both serum and phenol-red. It is possible that cadmium ions can bind to serum 
proteins in the medium and thereby reduce the accessibility of cadmium to the cells; however, 
in this study cadmium uptake by the cells was confirmed by analytical quantification. As for 
UVC irradiation, the medium with phenol-red slightly reduces the total dose due to some 
absorption (Brunborg, personal communication), but this “sun screen” effect is not large and 
the absolute dosimetry of UVC is not important. Our goal was not to measure the effects of a 
given cadmium concentration or UVC dose, but to evaluate their combined effects.   
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5.3. No differences were observed in cell-cycle progression 
Flow cytometry showed no consistent differences between treatment groups indicative of 
cell cycle arrest in G1, S or G2 phase. However, our flow data is limited and consists of 
results from different experiments and separate passages of cells. Cell cycle arrest at any of 
the cell cycle checkpoints could very well be masked by normal variation between cultures at 
different cell passages. In a study of chick embryos, cadmium treatment did not attenuate cell 
growth and proliferation (Thompson et al., 2005). On the other hand, a study performed on 
Chinese hamster ovary cells (CHO K1), knocked out for metallothionein (MT) and thus very 
sensitive to cadmium, demonstrated cell cycle arrest in response to low concentrations of 
cadmium (Yang et al., 2004). TGCT cells exhibit genetic abnormalities which stimulate cell 
transition through the G1 phase of the cell cycle (reviewed by von Eyben, 2004). 
Consequently, cell cycle arrest in G1 may be expected to be difficult to observe in 833K cells. 
With respect to UVC (ignoring cadmium pre-treatment), we do believe that some of the cell 
cultures, especially the ones treated with the highest doses (3, 5 and 10 J/m2) were detained in 
their cell cycle progress. In fact, the PARP-cleavage seen in UVC (3 J/m2) treated samples 
(Figure 4.13f) is an indication of S-phase arrest and early apoptosis. However, due to the 
limited incubation after UVC exposure, differences in cell-cycle progress between the 
treatments are just not seen. In conclusion, further testing is needed to establish the cell-cycle 
profiles elicited by the different treatments used in our study.   
5.4. DNA repair assays 
As previously described, UVC-induced DNA lesions are mainly handled by NER. 
Following exposure to various doses of UVC, 833K cells were incubated in the presence of 
RI and assayd for DNA single strand breaks using alkaline elution. Only the efficiency of the 
initial steps (damage recognition, incision and excision), of NER is assayed with this 
approach. Alternatively, we combined alkaline elution with the enzyme T4-pdg treatment, 
which specifically cleaves at UV induced lesions (Lloyd, 2005).  
5.4.1. Use of inhibitors revealed no apparent effects of cadmium on 
833K repair efficiency 
The use of inhibitors revealed no significant difference in incision of DNA lesions in 
833K cells pre-treated with cadmium compared to untreated cells. There was however a great 
deal of variation within the treatment groups, indicating unknown variations in experimental 
conditions. Both of the inhibitors used are highly toxic anti-cancer drugs which can inflict 
additional harm, possibly obscuring potential differences between cadmium treated and 
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untreated cells. Furthermore, the cells were only incubated for 1 hour after UVC exposure, 
which may be too short to establish a difference between the samples by measuring SSBs. 
Finally, a higher number of both sample and experimental replicates would have been 
preferable.  
5.4.2. Alkaline elution combined with enzyme treatment showed 
that cadmium inhibits NER 
 When using the T4-pdg enzyme, we did find cadmium to significantly attenuate DNA 
repair of UVC induced lesions. Our findings coincide with the results of a similar study (Fatur 
et al., 2003), which demonstrated effects of cadmium on NER of UVC lesions in CHO cells. 
Moreover, their findings implied that both the initial and the later steps of NER were affected 
by cadmium. This was based on a slow formation of DNA strand breaks in cadmium treated 
cells, and that the level of strand breaks did not decline after a 1 h recovery period. As 
mentioned in the introduction, studies have shown cadmium to inhibit the NER protein XPA, 
which plays an essential, multifunctional role in NER (Asmuss et al., 2000b); reviewed in 
(Hartwig et al., 2002b). In addition to binding damaged DNA, XPA recruits and interacts with 
other NER proteins such as ERCC1, TFIIH, RPA, and XPC. It is proposed by Hartwig and 
co-workers that the inhibitory effects of cadmium on XPA are due to displacement of zinc in 
the protein’s minimal DNA binding domain (MBD), resulting in conformational changes that 
disrupt DNA binding properties. However, it has also been shown that displacement of zinc 
with cadmium in XPA, only leads to negligible conformational changes of the protein 
(Buchko et al., 2000). The latter authors proposed that the effects of cadmium on XPA must 
be attributed to various modes of action. For instance, cadmium might bind to negatively 
charged surface areas on XPA, thereby interrupting binding to DNA, or the binding of 
cadmium to DNA itself could be the cause (Buchko et al., 2000). In general, moderate 
changes in the amount of a protein are often sufficient to cause serious biological effects. 
Cadmium inhibition of DNA repair is undoubtedly complex, and is most likely a consequence 
of several effects.  
5.5. Western blot analysis 
The mechanisms of cadmium-induced genotoxicity are diverse and several cellular 
functions, are affected some of which were described in the introduction. With this in mind, 
the induction levels of some proteins involved in DNA repair, cell cycle and apoptosis were 
studied.  
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833K cells are cancer cells, and thus their response to treatments might deviate from 
those of normal cells. Furthermore, protein turnover is variable; some proteins might be 
peaking while others are being degraded at a given time after exposure. The time at which the 
protein-induction levels are measured may very well affect the results. The protein samples 
used in this study were all extracted after 24 hours of incubation (including those treated with 
UVC at 20 hours and then further incubated for the remaining 4 hours). 
5.5.1. UVC treatment (but not cadmium) reduced the protein levels 
of XPC, whereas DDB2 was not affected. 
XPC and DDB2 (UV-DDB) are two of the proteins needed for initial recognition of 
DNA damage in the GGR pathway of NER. GGR removes the bulk of lesions in the overall 
genome. We therefore expected to find higher induction levels for both XPC and DDB2 in the 
samples treated with UVC, with or without cadmium pre-treatment. However, the levels of 
XPC were lower in the UVC treated samples (regardless of cadmium) compared to unexposed 
controls. The levels of DDB2, on the other hand, were unchanged after UVC, but showed a 
minor induction in cells treated with cadmium alone. 
5.5.2. P53 is involved in DNA repair and is stabilised by low levels 
of cadmium  
A study by Adimoolam (Adimoolam et al., 2002) on human colorectal cancer cells 
(HCT116) and human fibroblasts (WI38), demonstrated that functional p53 protein is required 
for proficient induction of XPC in response to UVC irradiation, and that p53 regulates the 
basal expression of XPC. (Hwang et al., 1999) demonstrated that the gene p48 which codes 
for UV-DDB also requires p53 for proper induction in response to UVC. Interestingly, we 
found that the levels of p53 were high in our UVC-exposed cells, and thus we expected these 
samples to show induced levels of XPC and DDB2 as well. Other studies have shown 
cadmium disrupts proper DNA binding ability of p53 in human breast cancer cells (MCF7) 
(Meplan et al., 1999).  Similar to XPA, inactivation of p53 by cadmium is believed to be a 
result of zinc displacement by cadmium in the protein, causing conformational changes. 
However the effects of cadmium are diverse also on p53 and its mode of action is likely to be 
dependent on concentration. Micromolar concentrations of cadmium are typically thought to 
activate p53 proteins (by both transcription and stabilisation of p53) via oxidative stress 
induction, while higher doses inactivate p53 activity. We found that phospho-p53 was 
strongly induced by cadmium independent of UVC irradiation, which supports this 
hypothesis. One way in which cadmium can inactivate a p53 response in cells is by inhibiting 
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p53 translocation to the nucleus (Godon et al., 2005). This inhibition is also believed to be 
brought about by conformational changes in p53 due to the displacement of zinc, leading to 
reduced transcription of p53 responsive genes. However, our data are still too limited to 
decide whether such a mechanism can explain the low levels of XPC and DDB2. Further 
measurements of protein levels, at different times after exposure, should be useful.  
Protein induction levels of XPA and ERCC1 displayed minor differences between 
treatment groups and the results are too limited for conclusions about their role in cadmium 
and UVC treated cells. With respect to PCNA, which is involved in NER and BER, it was 
evenly distributed in all samples, confirming that this protein is constitutively expressed; its 
presence is associated with its role as a co-factor in polymerase δ required for chromosomal 
DNA replication (Majka et al., 2004). 
5.5.3. UVC induced PARP cleavage  
The enzymes called Poly ADP-ribose polymerases, or PARPs, are zinc dependent 
enzymes involved in several cellular functions including DNA repair and apoptosis (Burkle, 
2005). PARP was evenly represented in all our samples. Both UVC and cadmium are shown 
to induce PARP cleavage in apoptosis (Oh et al., 2004;Nocentini, 2003), but we observed this 
induction after UVC whereas cadmium had no such effect. Correspondingly, our viability 
tests showed a ~ 15 % decline in viability of 833K cells in response to 3 J/m2 UVC. 
5.5.4. Cadmium induction of ERK and Cdk2 is counteracted by UVC 
It was mentioned in the introduction that cadmium has been shown to induce the MAP-
kinases; ERK1, ERK2, and p38 (Chao et al., 2001;Chuang et al., 2000;Lag et al., 2005). ERK 
is typically associated with cell survival and proliferation, whereas p38 is a promoter of 
apoptosis. Induced levels of these proteins may, however, vary in response to different 
cadmium concentrations, as can the effects of the kinases, depending on cell type, duration of 
exposure etc. Our results showed that phospho-ERK, which is the activated form of the 
kinase, was induced in all treated samples compared to control. The levels were high in cells 
treated with cadmium alone, in correspondence with the observations (Chao et al., 
2001;Chuang et al., 2000;Lag et al., 2005). The protein levels in co-exposed cells were lower 
compared to those seen for cadmium alone, but slightly higher than in cells exposed to UVC 
alone. The levels seen in co-exposed cells suggest that UVC counteracts the effects of 
cadmium induction of phospho-ERK. UVC treatment of cells pre-incubated with cadmium 
could for instance lead to dephosphorylation of active ERKs. As previously described, Cdk2 
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is involved in cell transition through G1/S and S/G2 of the cell cycle. We found that cadmium 
treated cells displayed the highest levels of Cdk2, while UVC and especially co-exposed cells 
had the lowest levels. The apparent induction by cadmium seems therefore to be counteracted 
by UVC similarly to what was seen for phospho-ERK. UVC has been shown to reduce Cdk2 
levels in Chinese hamster ovary cells (CHO k1), as a prelude to apoptosis (Liao et al., 2005). 
In the case of p38 and phospho-p38 we found that all samples, including controls, displayed 
uniform protein levels of both forms.  
Finally, we measured the levels of the “suicide protein” MGMT. The co-exposed cells 
displayed a reduction in MGMT protein levels, compared to the other samples. We did not 
expect to find any increased induction of MGMT due to the fact that neither UVC nor 
cadmium is an alkylating agent.  
We once more emphasise that these results are preliminary and do not justify further 
conclusions to be drawn.  
5.6. Microarray analysis 
In order to conduct a successful microarray analysis it is vital that the isolated total RNA 
is pure and of good quality. The RNA used in our study fulfilled these criteria, as shown in 
Results. Microarrays are cost effective in the sense that the output of biological information is 
exceptionally high, but each experiment is expensive. This has limited the number of arrays 
that could be used in the present study. Out of twelve microarrays, one complete set of 
parallels (i.e. four arrays) was discarded due to poor hybridisation. As a result we ended up 
with three merged biological replicates hybridised onto eight arrays comprising two (instead 
of three (or preferable more) technical parallels for each treatment and control. After scanning 
the arrays, the raw data was processed through the steps as previously described. The 
resulting normalised data (K-means and Hierarchical clusters, and the gene functional-
category table) show the trends in gene expression for each of the cell treatments. The K-
mean clusters for instance are visually very informative and depict appreciable differences in 
gene-expression profiles between the treatment groups. The next step in processing the data 
would be to conduct more detailed investigations of the genes represented in the various 
categories depicted in Table 4.3. Relevant genes are those involved in regulation of cell cycle, 
DNA repair, transcription, signal transduction, apoptosis etc. Such investigations might help 
to further elucidate the genes involved in cadmium co-genotoxicity. At first such a task might 
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seem daunting, considering that even our relatively modest results comprise over 600 
differentially expressed genes in response to the treatments.  
5.6.1. Large toxicogenomic databases may be used in future 
toxicological evaluation of new compounds 
Microarray data such us those generated by us for cadmium treated 833K cells may form 
part of large databases, accessible for anyone assessing the properties of new chemicals with 
potential use by consumers, in industry or in medicine. Large toxicogenomic databases can 
provide information on biological interactions by comparing expression patterns in new 
chemicals with those already present for existing chemicals. In this way, suspected 
environmental pollutants could be compared and classified. Toxicogenomics still represent a 
relatively young discipline; improvements, new products and databases in this field are 
rapidly being developed. While microarrays can hardly replace traditional investigative 
methods in the near future, they are already of great importance for the toxicologists. 
Comparing microarray results across laboratories still represents a great challenge. Universal 
standardisation of experimental procedures, data processing, gene annotation etc comprises 
major obstacles that must be resolved before the full potential of toxicogenomics can be put 
into use.  
In addition to reduced costs and more rapid evaluation, the development of this field is 
driven by a strong pressure to reduce the use of animals in chemicals testing. Animal 
experiments are the cause of much controversy, especially among the public, but increasingly 
also within the scientific community. Good alternative methods are therefore being 
developed, but again extensive validation is needed. A further aspect is the risk always 
involved when extrapolating toxicological effects found in animals to humans. Microarrays 
provide a means of studying transcriptional responses elicited by a chemical or other 
treatment, in both human and animals.  
6. Concluding remarks 
The aim of our study was to elucidate the complex nature of co-exposures by integrating 
traditional tests with toxicogenomics, i.e. microarray technology. Cadmium and UVC have 
served as model agents, and their separate and combined effects have been investigated with 
emphasis on DNA-damage repair, and gene expression profiles. We found that pre-incubation 
of 833K cells to a low cytotoxic level of cadmium significantly altered the cells’ response to 
ultraviolet radiation. Appreciable differences in DNA damage using alkaline elution were 
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observed between treatments, and several protein activities were altered as measured with 
Western analysis although these are preliminary data. The results from flow cytometry were 
inconsistent and may also be considered as preliminary. The microarray data suggest global 
changes in gene expression in the treated cells. These data should however be further analysed 
using other methods e.g. real-time PCR, but this has not been feasible within the scope of this 
thesis  
Based on the collective results of our investigations, we consider this approach as 
especially useful when studying effects of co-exposures to environmental toxicants.   
7. Future studies 
In this thesis we used UVC irradiation as a model for genotoxic agents producing DNA 
lesions that are repaired via NER. An extension of this work would be to explore combined 
effects of cadmium with other known substances in stead of UVC, e.g. the highly 
carcinogenic benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide (BPDE). Furthermore, other 
heavy metals interacting with repair enzymes or other proteins should be studied. The analysis 
of the microarray data was in this study limited to the identification of gene classes; a 
continuation of this analysis could be to identify single genes and their role in specific 
pathways.  
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9. Appendix A 
9.1. Materials 
9.1.1. Chemicals, antibodies and commercial kits 
Product Manufacturer  
β-Mercaptoethanol Sigma 
Acetic acid  Merck 
Acrylamide/bis solution (30 %)  BioRad 
Ammonium persulphate (APS) BioRad 
Anti-goat HRP-conjugate Zymed 
Anti-mouse HRP-conjugate Jackson Laboratories 
Anti-rabbit HRP- conjugate Jackson Laboratories 
Cytosine Arabinoside Sigma 
Bio-Rad CD Protein Assay Kit BioRad 
Bovine Serum Albumin (BSA) Sigma 
Bromophenol Blue Sigma 
Cdk2 (rabbit) Santa Cruz  
Citric acid monohydrate Jungbunzlauer Ges. m.b.h 
Complete mini  Roche 
Coomassie® Brilliant Blue BioRad 
DDB2 (Goat) Santa Cruz  
Developer (LX 24) Kodak 
diSodium hydrogen phosphate-dihydrate Merck 
Dithiothreitol Sigma 
Dry milk (Blotting Grade Blocker) BioRad 
EDTA Sigma 
Na2EDTA•2H2O Sigma 
ERCC1 (Mouse) Neomarkers 
Ethanol (Absolute)  Arcus 
Fairplay Microarray Labeling Kit Stratagene 
Fixer (AL 4) Kodak 
GAPDH (mouse) Biogenesis 
GenEluteTM Total RNA Kit Sigma 
Glycerol  Sigma 
Hoechst 33258 Calbiochem 
Hoechst 33342 Calbiochem 
Hydrochloric acid Merck 
Hydroxyurea Sigma 
Medical X-ray film, Super RX FUJI 
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Methanol Merck 
MGMT (mouse) Neomarkers 
n-Butanol  Merck 
Nitro-cellulose membrane BioRad 
p38 (rabbit) Cell Signalling tech 
p53 (rabbit) Cell Signalling tech 
PARP (mouse) Clontech 
PBS Dulbecco 
PCNA (mouse) Abcam 
Penicillin/Streptomycin (P/S) Cambrex 
phospho-Erk (Thr 202, Tyr 204) (mouse) Cell Signalling tech. 
phospho-p38 (Thr 180, Tyr 204) (rabbit) Cell Signalling tech. 
phospho-p53 (Ser 15) (rabbit) Cell Signalling tech. 
Pierce Supersignal West Dura Extended Duration substrate  PerBio 
Potassium-dihydrogen phosphate-dihydrate  Merck 
Potassium-dihydrogen phosphate Merck 
Potassium Hydroxide Merck 
Precision Plus ProteinTM Standards, Kaleidoscope  BioRad 
Propidium Iodide Sigma 
Proteinase K Merck 
RNA 6000 Nano LabChip Assay Agilent Technologies 
RPMI-medium 1640 with Hepes and L-glutamine  Bio Whittaker 
Sodium Chloride Merck 
Sodium dodecyl sulphate (SDS) KEBO Lab 
Sodium dodecyl sulphate (10 %) Sigma 
Sodium Hydroxide Merck 
Temed BioRad 
Thimerosal Sigma  
Trizma®base Sigma 
Trizma®Hydrochloride, Tris-HCl Sigma 
Trypan blue Biowhittaker 
Trypsin-EDTA Sigma 
Tween 20 BioRad 
XPA (mouse) Santa Cruz  
XPC (mouse) Abcam 
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9.2. Solutions 
9.2.1. DNA alkaline elution 
10X Merchant buffer 
1000 ml: 
81.8 g NACL 
2.0 g KH2PO4 
2.0 g KCL 
14.4 g Na2HPO4 • 2H2O 
Distilled water up to 1000 ml 
 
1X Merchant buffer (1.4 M NaCl, 15 mM KH2PO4, 27 mM KCl, 81mM Na2HPO4·2H2O) 
2000 ml:       
200 ml 10X Merchant buffer                        
7.44 g Na2EDTA                                                                                                                       
Distilled water up to 2000 ml                                              
PH was adjusted to 7.4 with 4 M NaOH. 
 
20 mM  Na2EDTA 
1000 ml:  
7.44 g Na2EDTA 
Distilled water up to 1000 ml 
pH was adjusted to 9.6 with 10 M NaOH. 
 
BE1 buffer 
1000 ml: 
1 mM Na2EDTA (0.37 g) 
100 mM KCl (7. 46 g) 
20 mM Tris-HCl (50 ml 1 M Tris-HCl)    
Distilled water up to 1000 ml 
pH was adjusted to 7.5 with 5 M KOH, and the solution was boiled to reduce air bubbles.     
 
BE1 buffer with 0.1 mg/ml BSA 
0.5 ml BSA stock (40 mg/ml) 
200 ml BE1 buffer 
 
50 µg/ml T4-pdg 
1 ml T4-pdg stock (6 mg/ml) 
120 ml BE1 buffer with 0.1 mg/ml BSA 
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10X Elution buffer 
1000 ml: 
74.4 g Na2EDTA 
14 g NaOH 
Distilled water up to 1000 ml 
 
1X Elution buffer (20 mM Na2EDTA) 
4000 ml:               
400 ml 10X Elution buffer 
3600 ml Distilled water 
pH was adjusted to 12.5 or 12.25 (If DNA was treated with T4-pdg), with 10 M NaOH.  
 
Lysis solution 
1000 ml: 
25 mM Na2EDTA (9.3 g) 
100 mM Glycine (7.5 g) 
1 % SDS (20 g)               
Distilled water up to 1000 ml 
pH was adjusted to 9.6 with 10 M NaOH, and the solution was boiled to reduce air bubbles. 
9.2.2. Microarray analysis 
Total RNA isolation 
All reagents provided in the GenEluteTM Total RNA Kit. 
 
RNA Integrity control (Bioanalyzer) 
All reagents provided in the RNA 6000 Nano LabChip Assay Kit. 
 
cDNA generation and Dye-coupling reaction 
All reagents provided in the Fairplay Microarray Labeling Kit. 
 
Microarray Pre-hybridisation solution 
0.1 % Bovine Serum Albumin (BSA) Fraction V (100 mg) 
5X SSC (25 ml 20X SSC: 3M Nacl, 0.3 M sodium citrate, pH 7.0) 
0.1 % SDS (1 ml 10 % SDS) 
Sterile water (~ 74 ml) 
First the BSA Fraction V was dissolved in 70 ml sterile water by gentle stirring, and then 20X SSC and SDS 
were added. Sterile water was added so that the final volume was 100 ml. 
 
Manuel hybridisation solution 
Labelled cDNA (~90 µl) 
50 % of total volume 2X SDS buffer (130 µl) 
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0.1 mg/ml sonicated herring sperm (2.6 µl of 10 mg/ml stock) 
RNAse free water (~40 µl) 
Total volume of 260 µl per hybridization.  
 
Post hybridisation solutions 
All solutions were sterile filtered. 
 
Wash 1 
2X SSC (100 ml 20X SSC) 
0.1 % SDS (10 ml 10 % SDS) 
5 mM DTT (0.1 g) 
Sterile water (898 ml) 
 
Wash 2 
0.1X SSC (5 ml 20X SSC) 
0.1 % SDS (10 ml 10 % SDS) 
Sterile water ( 985ml) 
 
Wash 3 
0.1X SSC (5 ml 20X SSC) 
Sterile water (995 ml) 
9.2.3. Western blot analysis 
1X Lysis solution (for preparation of protein extract) 
60 mM Tris-HCL (50 ml 0.5 M Tris-HCL pH 6.8) 
10 % glycerol (40 ml 100 % gyserol) 
2 % SDS (80 ml 10 % SDS) 
1 mM EDTA (4 ml 0.1 M EDTA)  
pH is adjusted to 6.8 with NaOH and dH2O is added up to 400ml. 
Protease inhibitor, Complete mini (14X): 70 µl/ml lysis solution. 
Phosphatase inhibitors:  
Sodium fluoride (NaF) (50 mM stock): 50 µl/ml lysis solution 
Β-glycerolphosphate (Stock 100X): 10µl/ ml lysis solution,   
Na3VO4 (stock 200mM): 5µl/ml lysis solution. 
 
Bio-Rad DC Protein Assay 
Reagent A, an alkaline copper tartrate solution 
Reagent B, a dilute Folin Reagent 
Reagent S, (SDS)  
A' = 1 ml solution A + 20 µl S.  
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All reagents were provided in the kit. 
 
10X Electrophoresis buffer 
2000 ml:  
60g TRIS Base (Tris-hydroxsymethyl-aminomethane) 
88g Glycine 
20g SDS (Sodium Dodecyl Sulphate) 
Distilled water up to 2000 ml 
 
1X Electrophoresis buffer 
1000 ml:  
100 ml of 10X Electrophoresis buffer 
900 ml distilled water 
 
10X Transfer buffer 
2000 ml:  
60 g, TRIS base 
288 g Glycine 
Distilled water up to 2000 ml 
 
1X Transfer buffer 
1000 ml:  
100 ml of 10X Transfer buffer 
700 ml distilled water 
200 ml methanol 
The methanol was added just before use to avoid evaporation. 
 
10X TBS-T (Tris buffer with Tween 20) – wash buffer 
5000 ml:  
10 mM Trizma base (60,5g) 
137 mM  NaCl (400g) 
0.1%Tween 20 (50ml) 
350 ml of 1M HCl 
Distilled water was added up to 5000 ml and pH adjusted to 7.6. The solution was then diluted 1 : 10 before use. 
Tween makes the removal of excess antibodies more efficient and reduces unspecified binding to the membrane. 
The risk is however that some proteins and peptides may be lost, in which case one should only wash with TBS 
(especially when measuring small proteins or peptides). The membranes should be stored in TBS not TBST. 
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10X TBS (Tris buffer) 
5000 ml:   
10 mM Trizma base (60,5g) 
137 mM  NaCl (400g) 
350 ml of 1M HCl 
Distilled water was added up to 5000 ml and pH adjusted to 7.6. The solution was then diluted 1 : 10 before use. 
Acrylamide separating and stacking gel 
For optimal separation of proteins the solutions should be de-gassed under vacuum. 
 
Separating gel 6 % 10 % 12 % 
Distilled water 3.95 ml 2.95 ml 2.45 ml 
Acrylamide 1,5 ml 2.5 ml 3.0 ml 
Buffer, pH 8,8 1.9 ml 1.9 ml 1.9 ml 
10 % SDS 75 µl 75 µl 75 µl 
APS 75 µl 75 µl 75 µl 
TEMED 6 µl 3 µl 3 µl 
 
Stacking gel 4 % 
Distilled water 2.03 ml 
Acrylamide 425 µl 
Buffer, pH 6,8 825 µl 
10 % SDS 33.5 µl 
APS 17 µl 
TEMED 3.5µl 
 
Coomassie Brilliant Blue staining solution 
0.1 % Coomassie Brilliant Blue 
50 % Methanol 
10 % Acetic acid 
0.1 g of Coomassie Brilliant Blue G was dissolved in 500 ml of methanol. 100 ml of acetic acid was added to the 
solution, and the volume was adjusted to 1000 ml with distilled water.  
 
Destain solution I 
40 % Methanol 
7 % Acetic acid 
400 ml methanol was mixed with 70 ml acetic acid and 530 ml distilled water. 
Destain solution II 
5 % Methanol 
7 % Acetic acid 
50 ml methanol was mixed with 70 ml acetic acid and 880 ml distilled water. 
